<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Cell Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Cell Biol</journal-id>
<journal-id journal-id-type="publisher-id">jcb</journal-id>
<journal-id journal-id-type="hwp">jcb</journal-id>
<journal-title-group>
<journal-title>The Journal of Cell Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9525</issn>
<issn pub-type="epub">1540-8140</issn>
<publisher>
<publisher-name>The Rockefeller University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26728853</article-id>
<article-id pub-id-type="pmc">4700483</article-id>
<article-id pub-id-type="publisher-id">201510032</article-id>
<article-id pub-id-type="doi">10.1083/jcb.201510032</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Defective control of pre–messenger RNA splicing in human disease</article-title>
<alt-title alt-title-type="short">Defective splicing control and disease</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chabot</surname>
<given-names>Benoit</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shkreta</surname>
<given-names>Lulzim</given-names>
</name>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Centre of Excellence in RNA Biology, Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec J1E 4K8, Canada</institution>
</aff>
<author-notes>
<corresp id="cor2">Correspondence to Benoit Chabot: <email>benoit.chabot@usherbrooke.ca</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>4</day>
<month>1</month>
<year>2016</year>
</pub-date>
<volume>212</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>27</lpage>
<history>
<date date-type="received">
<day>09</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>11</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 Chabot and Shkreta</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="openaccess">
<license-p>This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see <ext-link ext-link-type="uri" xlink:href="http://www.rupress.org/terms">http://www.rupress.org/terms</ext-link>). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0/">http://creativecommons.org/licenses/by-nc-sa/3.0/</ext-link>).</license-p>
</license>
</permissions>
<self-uri xlink:href="JCB_201510032_thumb.gif" xlink:role="icon"></self-uri>
<abstract>
<p>Examples of associations between human disease and defects in pre–messenger RNA splicing/alternative splicing are accumulating. Although many alterations are caused by mutations in splicing signals or regulatory sequence elements, recent studies have noted the disruptive impact of mutated generic spliceosome components and splicing regulatory proteins. This review highlights recent progress in our understanding of how the altered splicing function of RNA-binding proteins contributes to myelodysplastic syndromes, cancer, and neuropathologies.</p>
</abstract>
</article-meta>
</front>
<body>
<sec disp-level="2" id="s02">
<title>Introduction</title>
<p>Nearly all protein-encoding human genes have multiple exons that are combined in alternative ways to produce distinct mRNAs, often in an organ-specific, tissue-specific, or cell type–specific manner. Although documenting the function of this vast collection of splice variants is a challenging endeavor, the regulated production of splice variants is required for important functions encompassing virtually all biological processes. The growing recognition of splicing and alternative splicing as critical contributors to gene expression was accompanied by many new examples of how splicing defects are associated with human disease. As several excellent reviews have reported on this expanding, and sometimes causal, relationship (<xref ref-type="bibr" rid="bib108">Poulos et al., 2011</xref>; <xref ref-type="bibr" rid="bib129">Singh and Cooper, 2012</xref>; <xref ref-type="bibr" rid="bib166">Zhang and Manley, 2013</xref>; <xref ref-type="bibr" rid="bib22">Cieply and Carstens, 2015</xref>; <xref ref-type="bibr" rid="bib97">Nussbacher et al., 2015</xref>), the goal of this review is to highlight recent efforts in understanding how disease-associated mutations disrupt regulation of splicing. After an overview of basic concepts in splicing and splicing control, we discuss recently described defects in the control of splicing that suggest contributions to myelodysplastic syndromes (MDS), cancer, and neuropathologies.</p>
</sec>
<sec disp-level="2" id="s03">
<title>Splicing and splicing control</title>
<p>Intron removal is performed by the spliceosome (<xref ref-type="fig" rid="fig1">Fig. 1 A</xref>), whose assembly starts with the recognition of the 5′ splice site (5′ss), the 3′ splice site (3′ss), and the branch site by U1 small nuclear RNP (snRNP), U2AF, and U2 snRNP, respectively. Along with the U4/U6.U5 tri-snRNP, &gt;100 proteins are recruited to reconfigure the interactions between small nuclear RNAs, between small nuclear RNAs and the pre-mRNA, and to position nucleotides for two successive nucleophilic attacks that produce the ligated exons and the excised intron (<xref ref-type="bibr" rid="bib148">Wahl et al., 2009</xref>; <xref ref-type="bibr" rid="bib89">Matera and Wang, 2014</xref>). Fewer than 1,000 introns (i.e., ∼0.3%) are removed by the minor spliceosome, which uses distinct snRNPs (U11, U12, U4atac, and U6atac) but shares U5 and most proteins with the major spliceosome (<xref ref-type="bibr" rid="bib139">Turunen et al., 2013</xref>).</p>
<fig fig-type="figure" id="fig1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p><bold>Spliceosome assembly and transcription-coupled splicing.</bold> (A) Schematic representation of spliceosome assembly indicating the position of 5′ss, 3′ss, the branch point, and the polypyrimidine tract. Exons and introns are represented as solid cylinders and lines, respectively. Only a portion of spliceosome components are depicted, with some subunits of U2AF, U2 snRNP, and the tri-snRNP complex indicated. (B) Schematic representation of the chromatin-associated cotranscriptional assembly of splicing complexes on a nascent pre-mRNA. CTD, C-terminal domain of RNA polymerase II.</p>
</caption>
<graphic xlink:href="JCB_201510032_Fig1"></graphic>
</fig>
<p>Definition of intron borders often requires the collaboration of RNA-binding proteins (RBPs), such as serine arginine (SR) and heterogeneous nuclear RNPs (hnRNPs), which interact with specific exonic or intronic sequence elements usually located in the vicinity of splice sites. As the combinatorial arrangement of these interactions helps or antagonizes the early steps of spliceosome assembly (<xref ref-type="bibr" rid="bib41">Fu and Ares, 2014</xref>), one ambitious goal is to determine how cell-, tissue-, and disease-specific variations in the expression of these splicing regulators and their association near splice sites induce specific changes in alternative splicing (<xref ref-type="bibr" rid="bib10">Barash et al., 2010</xref>; <xref ref-type="bibr" rid="bib167">Zhang et al., 2010</xref>). This challenge is compounded by the fact that only a fraction of the &gt;1,000 RBPs has been studied (<xref ref-type="bibr" rid="bib46">Gerstberger et al., 2014</xref>) and that all RBPs have splice variants, usually of undetermined function. Moreover, the function of RBPs is often modulated by posttranslational modifications that occur in response to environmental insults and metabolic cues (<xref ref-type="bibr" rid="bib41">Fu and Ares, 2014</xref>).</p>
<p>An extra layer of complexity to our view of splicing control is added when we consider that experimentally induced decreases in the levels of core spliceosomal components also affect splice site selection (<xref ref-type="bibr" rid="bib117">Saltzman et al., 2011</xref>). Indeed, reducing the level of dozens of spliceosomal components, including SF3B1, U2AF, and tri-snRNP components, affects the production of splice variants involved in apoptosis and cell proliferation (<xref ref-type="bibr" rid="bib105">Papasaikas et al., 2015</xref>). Although it remains unclear whether variation in the levels and activity of generic factors is used to control splicing decisions under normal conditions, deficiencies in tri-snRNP proteins or in proteins involved in snRNP biogenesis are now frequently associated with aberrant splicing in disease (e.g., PRPF proteins in retinitis pigmentosa [<xref ref-type="bibr" rid="bib133">Tanackovic et al., 2011</xref>], the SMN protein in spinal muscular atrophy [SMA; <xref ref-type="bibr" rid="bib170">Zhang et al., 2008</xref>], and SF3B1, SRSF2, and U2AF1 in MDS [see Spliceosomal proteins in MDS section]). How mutations in generic splicing factors confer gene- and cell type–specific effects is an intriguing question. The suboptimal features of some introns that dictate this sensitivity may normally be mitigated by the high concentration or activity of generic factors. Consistent with this view, repression of PRPF8 alters the splicing of introns with weak 5′ss (<xref ref-type="bibr" rid="bib154">Wickramasinghe et al., 2015</xref>). Thus, deficiencies in the activity of generic spliceosome components may compromise the splicing of a subset of introns, contributing to the onset of disease.</p>
<p>As splicing decisions are usually made while the pre-mRNA is still being transcribed (<xref ref-type="fig" rid="fig1">Fig. 1 B</xref>), regulatory links with transcription and chromatin structure take place at several levels. First, spliceosome components and regulators are recruited to the transcription machinery (e.g., the C-terminal domain of RNA polymerase II) to facilitate their transfer onto the emerging nascent pre-mRNA (<xref ref-type="bibr" rid="bib13">Bentley, 2014</xref>). Second, the speed of the elongating polymerase provides a kinetic window for the assembly of enhancer or repressor complexes that influence commitment between competing pairs of splice sites (<xref ref-type="bibr" rid="bib13">Bentley, 2014</xref>; <xref ref-type="bibr" rid="bib94">Naftelberg et al., 2015</xref>). Third, posttranslational modifications of histones and chromatin remodeling factors impact the speed of transcription as well as the recruitment of adapters that interact with splicing regulators (<xref ref-type="bibr" rid="bib83">Luco et al., 2011</xref>; <xref ref-type="bibr" rid="bib72">Lee and Rio, 2015</xref>; <xref ref-type="bibr" rid="bib94">Naftelberg et al., 2015</xref>). Notably, histone modifications in specific chromatin regions can be triggered by Argonaute proteins bound to endogenous or exogenously provided small RNAs (<xref ref-type="bibr" rid="bib3">Alló et al., 2009</xref>; <xref ref-type="bibr" rid="bib4">Ameyar-Zazoua et al., 2012</xref>). Long noncoding RNAs (lncRNAs), whose expressions vary in human diseases (e.g., MALAT-1 in cancer), may also contribute to splicing control by interacting with splicing factors to regulate their availability, or by orchestrating local epigenetic modifications that impact the speed of transcription or the recruitment of adapters (<xref ref-type="bibr" rid="bib172">Zhou et al., 2014a</xref>; <xref ref-type="bibr" rid="bib47">Gonzalez et al., 2015</xref>).</p>
</sec>
<sec disp-level="2" id="s04">
<title>Shooting the pre-messenger by disrupting splicing control elements</title>
<p>More than 200 human diseases, including progeria and some forms of breast cancer and cystic fibrosis, are caused by point mutations that affect pre-mRNA splicing by destroying or weakening splice sites, or activating cryptic ones (<xref ref-type="bibr" rid="bib152">Wang et al., 2012</xref>), thereby producing mRNAs that encode defective proteins or that are targets for nonsense-mediated mRNA decay (NMD). Splicing defects can also lead to the cotranscriptional degradation of nascent pre-mRNAs (<xref ref-type="bibr" rid="bib32">Davidson et al., 2012</xref>; <xref ref-type="bibr" rid="bib143">Vaz-Drago et al., 2015</xref>). A splice site mutation in <italic>BRAF</italic> is associated with resistance to the anticancer agent vemurafenib, but inhibitors of the generic splicing factor SF3B1 decrease the production of the mutation-induced BRAF variant and inhibit drug-resistant cell proliferation (<xref ref-type="bibr" rid="bib107">Poulikakos et al., 2011</xref>; <xref ref-type="bibr" rid="bib116">Salton et al., 2015</xref>). Splice site variations can also have health-positive effects, as shown recently for a variant of <italic>LDLR</italic> that lowers non–high density lipoprotein cholesterol and protects against coronary artery disease (<xref ref-type="bibr" rid="bib50">Gretarsdottir et al., 2015</xref>). In addition to mutations at splicing signals themselves, mutations that destroy silencer or enhancer elements form another important group of disease-causing alterations that impact alternative splicing (<xref ref-type="bibr" rid="bib131">Sterne-Weiler and Sanford, 2014</xref>). Because more than half of the nucleotides in an exon may be part of splicing regulatory motifs (<xref ref-type="bibr" rid="bib20">Chasin, 2007</xref>), synonymous exon mutations, as well as an undetermined number of intron mutations, may further contribute to splicing misregulation that leads to disease. A recent computational analysis relying on RNA sequencing data from normal and disease samples and using &gt;650,000 single-nucleotide variations (SNVs) identified &gt;10,000 intronic and 70,000 missense and synonymous exonic SNVs occurring in splicing regulatory motifs that linked potential splicing defects with disease (<xref ref-type="bibr" rid="bib155">Xiong et al., 2015</xref>). Notably, the computational tool developed for this analysis predicted, with tantalizing accuracy, the impact of mutation on the direction and amplitude of splicing shifts associated with SMA and hereditary colorectal cancer and identified several intronic autism-associated SNVs with a high potential of splicing impact (<xref ref-type="bibr" rid="bib155">Xiong et al., 2015</xref>).</p>
</sec>
<sec disp-level="2" id="s05">
<title>Incapacitating the regulators</title>
<p>Disease-causing mutations in intronic or exonic control elements generally affect splicing by perturbing the binding of regulatory proteins that normally recognize them. The activity of the splicing regulators themselves can also be altered in disease. Changes in the nuclear level of regulators, including RBFOX2, hnRNP, and SR proteins, often occur in cancer (<xref ref-type="bibr" rid="bib144">Venables et al., 2009</xref>; <xref ref-type="bibr" rid="bib166">Zhang and Manley, 2013</xref>). Although these changes frequently produce splice variants that affect cell cycle control, apoptosis, cell motility, and invasion, the molecular mechanisms that lead to these alterations and to specific downstream events that promote cancer remain largely unclear (<xref ref-type="bibr" rid="bib166">Zhang and Manley, 2013</xref>; <xref ref-type="bibr" rid="bib126">Shilo et al., 2015</xref>). Another way to alter the activity of splicing regulators is through sequestration. This is the case in DM1 and DM2 myotonic dystrophies, where muscleblind-like (MBNL) proteins are recruited to mRNAs carrying expansions of CUG and CCUG repeats, respectively. This sequestration compromises MBNL binding to normal RNA targets, deregulates the expression of CUGBP1, and alters alternative splicing of hundreds of transcripts not only in muscle tissues but also in the brain (<xref ref-type="bibr" rid="bib108">Poulos et al., 2011</xref>; <xref ref-type="bibr" rid="bib19">Charizanis et al., 2012</xref>; <xref ref-type="bibr" rid="bib38">Echeverria and Cooper, 2012</xref>; <xref ref-type="bibr" rid="bib12">Batra et al., 2014</xref>; <xref ref-type="bibr" rid="bib48">Goodwin et al., 2015</xref>). The formation of cytoplasmic aggregates, possibly also triggered by mRNAs carrying nucleotide expansions, is frequently associated with neuropathological diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD; see Splicing control defects in neuropathological and muscle-related disease section). In other instances, particularly in cancer, the localization and/or activity of splicing factors are misregulated by posttranslational modifications, e.g., phosphorylation (<xref ref-type="bibr" rid="bib95">Naro and Sette, 2013</xref>). Mutation of generic spliceosomal components is also becoming a recurrent theme in disease, and recent advances in this area are mentioned throughout our review. Likewise, with the increasing awareness that splicing decisions are coordinated with transcription, and thus with processes that modify chromatin, splicing alterations provoked by disease-associated lncRNAs and chromatin-modifying enzymes are likely to become an emerging focus of inquiry.</p>
</sec>
<sec disp-level="2" id="s06">
<title>Impairing splicing factors to promote cancer</title>
<p>Here, we highlight recent work that has focused on the role of spliceosomal components in MDS, a heterogeneous group of disorders that affect hematopoietic progenitor cells and the production of different types of blood cells. MDS often progress to fully malignant acute myeloid leukemia (AML) with the abnormal accumulation of hematopoietic precursors arrested at an early stage of differentiation. We then provide examples of network restructuring of alternative splicing regulators that have been more solidly associated with carcinogenesis or that may constitute new concepts that link splicing factors with the emergence and maintenance of cancer.</p>
</sec>
<sec disp-level="2" id="s07">
<title>Spliceosomal proteins in MDS</title>
<p>Somatic heterozygous mutations in any of the spliceosomal proteins SF3B1, SRSF2, U2AF1, and the U2AF-related gene ZRSR2 occur in &gt;50% of all MDS patients (<xref ref-type="bibr" rid="bib104">Papaemmanuil et al., 2011</xref>; <xref ref-type="bibr" rid="bib111">Quesada et al., 2011</xref>; <xref ref-type="bibr" rid="bib162">Yoshida et al., 2011</xref>). No homozygous mutations have been described, and almost all mutations are missense, usually occurring at conserved positions. Bone marrow and cancer cells harboring these mutations display splicing abnormalities (<xref ref-type="bibr" rid="bib87">Makishima et al., 2012</xref>; <xref ref-type="bibr" rid="bib110">Przychodzen et al., 2013</xref>; <xref ref-type="bibr" rid="bib45">Gentien et al., 2014</xref>). This may be a direct consequence of the specific mutations because the RNAi-mediated depletion of wild-type SF3B1, SRSF2, and U2AF1 in a variety of cell types or the expression of mutated proteins in nonhematopoietic and cancer cell lines also disrupts alternative splicing (<xref ref-type="bibr" rid="bib88">Massiello et al., 2006</xref>; <xref ref-type="bibr" rid="bib101">Pacheco et al., 2006</xref>; <xref ref-type="bibr" rid="bib49">Graubert et al., 2011</xref>; <xref ref-type="bibr" rid="bib162">Yoshida et al., 2011</xref>; <xref ref-type="bibr" rid="bib145">Venables et al., 2013</xref>; <xref ref-type="bibr" rid="bib17">Brooks et al., 2014</xref>; <xref ref-type="bibr" rid="bib124">Shao et al., 2014</xref>; <xref ref-type="bibr" rid="bib36">Dolatshad et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Kfir et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Komeno et al., 2015</xref>; <xref ref-type="bibr" rid="bib105">Papasaikas et al., 2015</xref>). Here, we will summarize a set of studies that provide tantalizing insight into how mutated SRSF2, SF3B1, U2AF1, and ZRSF2 affect splicing programs and alter hematopoiesis in mice and MDS patients (<xref ref-type="fig" rid="fig2">Fig. 2</xref>).</p>
<fig fig-type="figure" id="fig2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p><bold>Diagram summarizing how splicing factors and telomere deficiencies reproduce hematopoietic defects found in MDS.</bold> The impact of each deficiency on alternative splicing is indicated with an emphasis on shared alterations (see Spliceosomal proteins in MDS for details).</p>
</caption>
<graphic xlink:href="JCB_201510032_Fig2"></graphic>
</fig>
<sec id="s08">
<title>SRSF2</title>
<p>Notably, telomerase-negative mice with short telomeres that induce a persistent DNA damage response (DDR) present hematopoietic defects that recapitulate the clinical features of human MDS (<xref ref-type="bibr" rid="bib25">Colla et al., 2015</xref>). Moreover, this telomere deficiency is associated with a decrease in the level of splicing factors that are frequently mutated in MDS (e.g., SRSF2, U2AF2, SF3B2, and SF3A3). Progenitor cells with deficient telomeres produce defective transcripts encoding components involved in DNA repair and chromatin structure. One splicing change reduces the level of the DNA methyl transferase DNMT3a, whose frequent mutation in MDS patients contributes to rapid progression to AML (<xref ref-type="bibr" rid="bib149">Walter et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Colla et al., 2015</xref>). SRSF2 is a splicing regulator that contributes to both generic and alternative splicing (<xref ref-type="bibr" rid="bib81">Long and Caceres, 2009</xref>). The impact of short telomeres on the expression of SRSF2 inspired <xref ref-type="bibr" rid="bib25">Colla et al. (2015)</xref> to create SRSF2-haploinsufficient mice. Remarkably, these mice display impaired erythroid differentiation and express several of the defective alternative splicing events caused by telomere dysfunction. Further, they aberrantly splice transcripts encoding components involved in telomere maintenance, potentially providing a feedback loop that may elicit more splicing defects (<xref ref-type="bibr" rid="bib25">Colla et al., 2015</xref>).</p>
<p>Importantly, the MDS-associated P95H mutation in SRSF2 shifts the affinity of SRSF2 to a subset of binding sites (<xref ref-type="bibr" rid="bib66">Kim et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Komeno et al., 2015</xref>; <xref ref-type="bibr" rid="bib168">Zhang et al., 2015a</xref>), thus providing an explanation for the fact that the recapitulation of splicing defects observed in SRSF2-haploinsufficient mice is only partial (<xref ref-type="bibr" rid="bib25">Colla et al., 2015</xref>). CD34<sup>+</sup> hematopoietic stem cells from MDS patients with the P95H mutation have defects in the production of splice variants involved in telomere maintenance, DNA repair, and chromatin remodeling (<xref ref-type="bibr" rid="bib25">Colla et al., 2015</xref>). Finally, murine bone marrow cells expressing the SRSF2-P95H mutant display features that are characteristic of MDS, including increased proliferation of progenitor cells and impaired differentiation (<xref ref-type="bibr" rid="bib66">Kim et al., 2015</xref>). One of the P95H-mediated splicing alterations in mice reduces the expression of the histone methyl transferase EZH2, an outcome also occurring in human cells expressing mutant SRSF2. Strikingly, restoring expression of EZH2 in SRSF2 mutant mice partially rescues the hematopoietic defect (<xref ref-type="bibr" rid="bib66">Kim et al., 2015</xref>). Overall, these studies provide strong evidence that MDS-associated mutations in SRSF2 affect the production of splice variants involved in chromatin structure that in turn elicit hematopoietic defects.</p>
</sec>
<sec id="s09">
<title>SF3B1</title>
<p>SF3B1 is a U2 snRNP–associated protein involved in branch point selection (<xref ref-type="bibr" rid="bib28">Corrionero et al., 2011</xref>). The depletion of SF3B1 impairs the growth and the differentiation of myeloid cell lines (<xref ref-type="bibr" rid="bib36">Dolatshad et al., 2015</xref>). SF3B1 haploinsufficiency in mice compromises the repopulating ability of hematopoietic stem cells, but is not sufficient to induce MDS (<xref ref-type="bibr" rid="bib146">Visconte et al., 2012</xref>; <xref ref-type="bibr" rid="bib90">Matsunawa et al., 2014</xref>; <xref ref-type="bibr" rid="bib150">Wang et al., 2014a</xref>; <xref ref-type="bibr" rid="bib36">Dolatshad et al., 2015</xref>). Decreasing the levels of SF3B1 in myeloid cell lines alters the alternative splicing of transcripts encoding components involved in apoptosis and cell cycle control. Interestingly, in bone marrow cells and progenitor bone marrow stem cells from SF3B1-mutated MDS patients, the expression and splicing of genes/transcripts associated with mitochondrial and heme-related functions are altered, providing a link with the abnormal iron homeostasis observed in MDS patients (<xref ref-type="bibr" rid="bib146">Visconte et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Dolatshad et al., 2015</xref>). Notably, iron homeostasis influences alternative splicing by modulating the activity of SRSF7 (<xref ref-type="bibr" rid="bib135">Tejedor et al., 2015</xref>). Interestingly, it has been observed that SRSF7 is itself abnormally spliced in MDS patients carrying the SF3B1 mutation (<xref ref-type="bibr" rid="bib36">Dolatshad et al., 2015</xref>). We speculate that this defective splicing may be responsible, at least in part, for the noted heme deficiency in MDS patients.</p>
<p>SF3B1 is also part of a complex with BCLAF1, U2AF, and PRPF8 that is recruited to chromatin-bound BRCA1 to stimulate the splicing of transcripts encoding factors involved in DNA repair and the DDR (<xref ref-type="bibr" rid="bib119">Savage et al., 2014</xref>). In line with this finding, several DNA repair and DDR genes (e.g., <italic>ABL1</italic>,<italic> BIRC2</italic>, and <italic>NUMA1</italic>) produce aberrantly spliced transcripts in cells of patients with SF3B1 mutations (<xref ref-type="bibr" rid="bib36">Dolatshad et al., 2015</xref>). Interestingly, one splicing alteration in these patient cells occurs in EZH1, a functional homologue of the histone methyl transferase EZH2, which is also defectively spliced in SRSF2-mutated cells and contributes to the MDS phenotype (<xref ref-type="bibr" rid="bib146">Visconte et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Dolatshad et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Kim et al., 2015</xref>). Notably, the expression and alternative splicing of transcripts encoding RNA-processing factors, including PRPF8 and U2AF2, are also affected in SF3B1-mutated cells (<xref ref-type="bibr" rid="bib36">Dolatshad et al., 2015</xref>). This observation is important because mutations in PRPF8 and U2AF2 are found in MDS patients (<xref ref-type="bibr" rid="bib15">Boultwood et al., 2014</xref>). However, although PRPF8 mutations are associated with alternative splicing defects (<xref ref-type="bibr" rid="bib70">Kurtovic-Kozaric et al., 2015</xref>), U2AF2 mutations appear neutral (<xref ref-type="bibr" rid="bib124">Shao et al., 2014</xref>). Overall, these results suggest that SF3B1 mutations alter the splicing of transcripts involved in chromatin structure, DNA repair, and the DDR, thereby possibly providing an explanation for the accumulation of DNA damage in hematopoietic progenitor cells of MDS patients (<xref ref-type="bibr" rid="bib173">Zhou et al., 2013</xref>). A function for SF3B1 in splice site selection has recently been associated with a specific interaction with histone marks that are enriched in exons (<xref ref-type="bibr" rid="bib65">Kfir et al., 2015</xref>). Although SF3B1 mutations often occur in the C-terminal HEAT repeats involved in protein–protein interactions, it remains to be shown whether these mutations affect the recruitment of SF3B1 to chromatin. If they do, combining a mutated SF3B1 with chromatin modification defects may amplify splicing alterations, gradually leading to more detrimental hematopoietic deficiencies.</p>
</sec>
<sec id="s10">
<title>U2AF1</title>
<p>U2AF1 is the smaller of two proteins that make up the U2AF heterodimer implicated in generic 3′ss recognition. Although the U2AF1-S34F mutation elicits hematopoietic abnormalities in mice that compromise the repopulating ability of stem cells, it does not elicit MDS (<xref ref-type="bibr" rid="bib127">Shirai et al., 2015</xref>). Many splicing defects in MDS patients with U2AF1 mutations occur in transcripts that encode components involved in cell cycle and splicing control (<xref ref-type="bibr" rid="bib110">Przychodzen et al., 2013</xref>). Expression of mutated U2AF1 proteins in a human erythroleukemic cell line causes thousands of splicing alterations, including some in transcripts encoding components involved in DNA methylation (e.g., DNMT3B, also affected by mutations in SF3B1), DDR, and apoptosis (<xref ref-type="bibr" rid="bib58">Ilagan et al., 2015</xref>). Different U2AF1 mutations alter its binding to 3′ss in different ways and lead to distinct yet overlapping splicing defects (<xref ref-type="bibr" rid="bib17">Brooks et al., 2014</xref>; <xref ref-type="bibr" rid="bib124">Shao et al., 2014</xref>; <xref ref-type="bibr" rid="bib58">Ilagan et al., 2015</xref>). A meta-transcriptome analysis using samples from U2AF1-S34F mutant mice, AML patients with U2AF1 mutations, and primary bone marrow cells overexpressing U2AF1-S34F uncovered common splicing alterations in transcripts encoding splicing proteins and components that are mutated in MDS and AML, or that are involved in hematopoietic stem cell function. These observations provide strong support to the view that mutated U2AF1 elicits abnormal hematopoiesis (<xref ref-type="bibr" rid="bib127">Shirai et al., 2015</xref>).</p>
</sec>
<sec id="s11">
<title>ZRSR2</title>
<p>ZRSR2 has been implicated in the splicing of introns that use the U12-dependent minor spliceosome in transcripts encoding cancer-relevant proteins such as PTEN, MAPK1, MAPK3, BRAF, and E2F2 (<xref ref-type="bibr" rid="bib85">Madan et al., 2015</xref>). MDS-associated mutations in ZRSR2 are often inactivating, and depleting ZRSR2 reduces the growth and clonogenic potential of leukemia cell lines and alters the differentiation potential of human CD34<sup>+</sup> bone marrow cells (<xref ref-type="bibr" rid="bib85">Madan et al., 2015</xref>).</p>
<p>Overall, the studies mentioned above suggest that alternative splicing likely makes a crucial contribution to the clinical evolution of MDS (<xref ref-type="fig" rid="fig2">Fig. 2</xref>). Mutations in SRSF2, U2AF1, and SF3B1 may elicit a shared set of splicing alterations that trigger common hematopoietic defects and predispose stem cells to cancer development. The insight gained by studying the contribution of mutated splicing factors to MDS is likely to benefit our understanding of how mutations in splicing factors lead to cancer in general because mutations in SF3B1, U2AF1, and SRSF2 are also found in a variety of solid tumors (<xref ref-type="bibr" rid="bib62">Kandoth et al., 2013</xref>; <xref ref-type="bibr" rid="bib120">Scott and Rebel, 2013</xref>; <xref ref-type="bibr" rid="bib86">Maguire et al., 2015</xref>). Although a recent compilation indicates that splicing factor genes are frequently mutated in different types of cancer (<xref ref-type="bibr" rid="bib132">Sveen et al., 2015</xref>), a more extensive characterization of the functional impact of these mutations will be required to determine whether these alterations preferentially contribute to specific types of cancer.</p>
</sec>
</sec>
<sec disp-level="2" id="s12">
<title>An integrating hypothesis: Altered RBPs cause R loops and persistent DDR signaling that alter splicing</title>
<p>Although mutated SF3B1 and U2AF1 are expected to impact branch site/3′ss selection directly, we speculate that decreases in the level, and changes in the RNA binding specificity of splicing factors may also cause a second wave of alternative splicing changes through activation of the DDR (<xref ref-type="fig" rid="fig3">Fig. 3</xref>). This model is based on the observation that when core spliceosomal components are delocalized or when RNA-processing factors such as SRSF1 and RNPS1 are depleted, R loop formation occurs and triggers the DDR to impact alternative splicing (<xref ref-type="bibr" rid="bib75">Li and Manley, 2005</xref>; <xref ref-type="bibr" rid="bib77">Li et al., 2007</xref>; <xref ref-type="bibr" rid="bib37">Domínguez-Sánchez et al., 2011</xref>; <xref ref-type="bibr" rid="bib137">Tresini et al., 2015</xref>). If we are correct, drops in the level or changes in the activity of SRSF2, SF3B1, and U2AF1 may perturb alternative splicing through persistent R loop–mediated activation of the DDR (<xref ref-type="fig" rid="fig3">Fig. 3</xref>), a consequence that would be consistent with the noted accumulation of DNA damage in MDS progenitor cells (<xref ref-type="bibr" rid="bib173">Zhou et al., 2013</xref>). DNA damage affects the expression, modification, and localization of several splicing regulatory proteins (<xref ref-type="bibr" rid="bib128">Shkreta and Chabot, 2015</xref>). Likewise, DNA damage caused by deficient telomeres in mice alters the expression of splicing regulators (<xref ref-type="bibr" rid="bib25">Colla et al., 2015</xref>). Importantly, alternative splicing defects in MDS patients and MDS mouse models affect variants involved in apoptosis, cell cycle control, DNA repair, splicing control, and chromatin structure (<xref ref-type="fig" rid="fig3">Fig. 3</xref>), precisely matching the functional categories of transcripts whose alternative splicing is affected by DNA-damaging agents (<xref ref-type="bibr" rid="bib128">Shkreta and Chabot, 2015</xref>). As drops in the activity of splicing factors are frequently associated with human pathologies, this model may be applicable to a variety of diseases in addition to MDS, including myotonic dystrophies, retinitis pigmentosa, ALS, and FTD.</p>
<fig fig-type="figure" id="fig3" orientation="portrait" position="float">
<label>Figure 3.</label>
<caption>
<p><bold>Model proposing that changes in alternative splicing triggered by mutations in SF3B1, SRSF2, and U2AF1 also occur through activation of the DDR.</bold> Drops in the activity or changes in the binding specificities of splicing factors alter splice site selection directly but are also proposed to promote the formation of R loops when segments of nascent pre-mRNAs are not adequately bound by splicing factors. R loop formation in turn triggers the DDR to elicit splicing changes in transcripts encoding DNA repair, chromatin structure, cell cycle and splicing control, and apoptotic components.</p>
</caption>
<graphic xlink:href="JCB_201510032_Fig3"></graphic>
</fig>
</sec>
<sec disp-level="2" id="s13">
<title>The epithelial–mesenchymal/mesenchymal–epithelial transition connection</title>
<p>Cancer metastasis involves cell migration and tissue invasion through reversible transitions from mesenchymal to epithelial cell types (mesenchymal–epithelial and epithelial–mesenchymal transition [MET and EMT, respectively]; <xref ref-type="fig" rid="fig4">Fig. 4</xref>; <xref ref-type="bibr" rid="bib157">Yang and Weinberg, 2008</xref>). ESRPs and RBFOX2 control the alternative splicing of several transcripts encoding cell adhesion proteins involved in the epithelial or mesenchymal phenotypes (<xref ref-type="bibr" rid="bib125">Shapiro et al., 2011</xref>; <xref ref-type="bibr" rid="bib145">Venables et al., 2013</xref>; <xref ref-type="bibr" rid="bib16">Braeutigam et al., 2014</xref>). A splice variant of the tyrosine kinase receptor RON that promotes cell migration and activates EMT is controlled by antagonistic interactions involving SRSF1 and hnRNP A1, A2, and H proteins (<xref ref-type="bibr" rid="bib74">LeFave et al., 2011</xref>; <xref ref-type="bibr" rid="bib14">Biamonti et al., 2014</xref>). Likewise, hnRNP M antagonizes ESRP in the splicing of the cell adhesion molecule CD44 and plays a key role in the metastatic behavior of breast cancer cells in mouse models (<xref ref-type="bibr" rid="bib156">Xu et al., 2014</xref>). In contrast, RBM47 behaves as a suppressor of breast cancer progression and metastasis (<xref ref-type="bibr" rid="bib142">Vanharanta et al., 2014</xref>). Consistent with their role in metastasis, the expression of hnRNP M and RBM47 is respectively high and low in aggressive human breast cancer (<xref ref-type="bibr" rid="bib142">Vanharanta et al., 2014</xref>; <xref ref-type="bibr" rid="bib156">Xu et al., 2014</xref>). LIN28A, the expression of which increases in the HER2 breast cancer subtype, interacts with hnRNP A1 to modulate the production of splice variants of ENAH that is associated with breast cancer metastasis (<xref ref-type="bibr" rid="bib35">Di Modugno et al., 2007</xref>; <xref ref-type="bibr" rid="bib159">Yang et al., 2015</xref>). In addition to the lncRNA <italic>MALAT1</italic>, which is implicated in metastasis, possibly by controlling alternative splicing (<xref ref-type="bibr" rid="bib138">Tripathi et al., 2010</xref>; <xref ref-type="bibr" rid="bib52">Gutschner et al., 2013</xref>), another lncRNA modifies chromatin to prevent the recruitment of a repressive chromatin-splicing adapter complex that normally enforces the mesenchymal-specific splicing of <italic>FGFR2</italic> (<xref ref-type="bibr" rid="bib47">Gonzalez et al., 2015</xref>). lncRNAs may act on opposite functional sides of the oncogenic pathway. On the one hand, the lncRNA <italic>INXS</italic>, which interacts with Sam68 to favor the production of the proapoptotic Bcl-xS splice variant, is down-regulated in tumors and its overexpression in mouse xenograft models elicits tumor regression (<xref ref-type="bibr" rid="bib33">DeOcesano-Pereira et al., 2014</xref>). On the other hand, the lncRNA <italic>FAS-AS1</italic> interacts with RBM5 to reduce expression of the prosurvival soluble FAS variant (<xref ref-type="bibr" rid="bib123">Sehgal et al., 2014</xref>). Other lncRNAs that have been implicated in cancer include <italic>linc-p21</italic>, <italic>PANDA</italic>, <italic>TUG1</italic>, and <italic>Pint</italic>, but their impact on splicing and their contribution to cancer and metastasis are speculative and need to be investigated in more detail (<xref ref-type="bibr" rid="bib151">Wang et al., 2014b</xref>; <xref ref-type="bibr" rid="bib165">Zhang and Peng, 2015</xref>).</p>
<fig fig-type="figure" id="fig4" orientation="portrait" position="float">
<label>Figure 4.</label>
<caption>
<p><bold>Defects in alternative splicing affect EMTs.</bold> (A–D) Epithelial and mesenchymal interconversion (A) are affected by splicing factors that control the alternative splicing events associated with these transitions as depicted for the RON (B), CD44 (C), and ENAH (D) transcripts. H, hnRNP H; M, hnRNP M; MET, mesenchymal–epithelial transition; X, unknown protein.</p>
</caption>
<graphic xlink:href="JCB_201510032_Fig4"></graphic>
</fig>
</sec>
<sec disp-level="2" id="s14">
<title>The MYC splicing connection</title>
<p>The overexpression of MYC contributes to malignant transformation and is associated with many cancers. Several studies have established a role for MYC in splicing control (<xref ref-type="fig" rid="fig5">Fig. 5</xref>). MYC contributes to cancer metabolism and tumor growth by increasing the levels of splicing regulators PTBP1, hnRNP A1, and hnRNP A2 that shift the production of pyruvate kinase from splice variant PKM1, which drives oxidative phosphorylation, to PKM2, which elicits aerobic glycolysis (<xref ref-type="bibr" rid="bib21">Christofk et al., 2008</xref>; <xref ref-type="bibr" rid="bib31">David et al., 2010</xref>). In glioblastoma, the up-regulation of hnRNP A1 promotes the splicing of a transcript encoding the MYC-interacting partner Max to generate ΔMax, producing a feed-forward loop that enhances MYC function and hnRNP A1 expression (<xref ref-type="fig" rid="fig5">Fig. 5</xref>; <xref ref-type="bibr" rid="bib8">Babic et al., 2013</xref>). MYC also stimulates the expression of the SR protein SRSF1, which drives oncogenesis through alternative splicing of a network of transcripts encoding signaling molecules (e.g., RON and MKNK2) and transcription factors (e.g., BIN1; <xref ref-type="bibr" rid="bib30">Das and Krainer, 2014</xref>). SRSF1 also elicits the production of variants, such as CASC4 with antiapoptotic function, as well as MDM2 and cyclin D1 variants with prooncogenic properties (<xref ref-type="bibr" rid="bib100">Olshavsky et al., 2010</xref>; <xref ref-type="bibr" rid="bib5">Anczuków et al., 2012</xref>, <xref ref-type="bibr" rid="bib6">2015</xref>; <xref ref-type="bibr" rid="bib26">Comiskey et al., 2015</xref>). Positive feedback likely occurs because the SRSF1-mediated splice variant BIN1-12a no longer binds to MYC and lacks tumor suppressor activity (<xref ref-type="bibr" rid="bib42">Ge et al., 1999</xref>; <xref ref-type="bibr" rid="bib63">Karni et al., 2007</xref>). KRAS mutations that are frequently found in colorectal cancer activate the MAPK–extracellular signal-regulated kinase pathway to increase the level of the transcription factor ELK1 that in turn increases MYC with the expected impact on the production of PKM2 (Hollander, D., and Ast, G., personal communication). The activated MAPK–extracellular signal-regulated kinase pathway also stimulates the expression of Sam68, which increases the level of SRSF1 through alternative splicing (<xref ref-type="bibr" rid="bib91">Matter et al., 2002</xref>; <xref ref-type="bibr" rid="bib141">Valacca et al., 2010</xref>). Interestingly, the expression of SRSF1 is also stimulated by the anticancer drug gemcitabine, producing a splice variant of MKNK2 that phosphorylates eIF4E to promote cell growth and drug resistance (<xref ref-type="bibr" rid="bib1">Adesso et al., 2013</xref>). Gemcitabine resistance is also provided by the expression of PKM2 through the increased production of PTBP1 (<xref ref-type="bibr" rid="bib18">Calabretta et al., 2015</xref>).</p>
<fig fig-type="figure" id="fig5" orientation="portrait" position="float">
<label>Figure 5.</label>
<caption>
<p><bold>MYC splicing connections in cancer.</bold> As described in the text, MYC acts as master regulator by controlling the expression of splicing factors hnRNP A1, A2, PTBP1, and SRSF1, which promote changes that favor the growth of cancer cells and provide positive feedback loops that further stimulate MYC expression. The KRAS–MAPK pathway, which is relevant to colorectal cancer (KRAS and BRAF mutations) and melanomas (BRAF mutations), converges on the MYC-mediated splicing program through ELK1, which stimulates MYC expression, and Sam68, which improves the production of SRSF1 through alternative splicing. Red arrows are used to indicate impact on alternative splicing.</p>
</caption>
<graphic xlink:href="JCB_201510032_Fig5"></graphic>
</fig>
</sec>
<sec disp-level="2" id="s15">
<title>Splicing factor addiction</title>
<p>The term “oncogene addiction” has been used in the cancer field to describe the increased dependence of cancers on oncogenes for growth and survival (<xref ref-type="bibr" rid="bib84">Luo et al., 2009</xref>). Recent results suggest that there is an analogous hypersensitivity of cancer cells on splicing factors. This relationship was established when it was noted that MYC-regulated genes and pathways provoke a general increase in pre-mRNA synthesis that imposes a strain on generic splicing (<xref ref-type="bibr" rid="bib56">Hsu et al., 2015</xref>; <xref ref-type="bibr" rid="bib68">Koh et al., 2015</xref>). The fact that MYC up-regulates enzymes that modify snRNP proteins in cancer cells is consistent with the high demand for spliceosome components (<xref ref-type="bibr" rid="bib68">Koh et al., 2015</xref>). Nevertheless, MYC-driven cancer cells are more sensitive to depletions of spliceosome components such as U2AF1 and SF3B1 (<xref ref-type="bibr" rid="bib56">Hsu et al., 2015</xref>). This splicing stress may also affect the production of functionally important splice variants because decreases in the level or activity of generic spliceosome components also affect alternative splicing. Other cancers may be similarly addicted to splicing factors. For example, PRPF6, a component of the tri-snRNP complex, is overexpressed in a subset of primary and metastatic colon cancers, and its depletion by RNAi in cell lines reduces cell growth and decreases the production of the oncogenic ZAK kinase splice variant (<xref ref-type="bibr" rid="bib2">Adler et al., 2014</xref>). Likewise, expression of splicing regulator SRSF10 is increased in aggressive colon cancers. The siRNA-mediated depletion of SRSF10 decreases tumor formation in mice, an effect that is mediated, at least in part, by a drop in the production of the oncogenic splice variant of the splicing factor BCLAF1 (<xref ref-type="bibr" rid="bib174">Zhou et al., 2014b</xref>). Thus, the overall stimulation in gene expression in cancer cells may increase their reliance on splicing factors, hence providing avenues to explore novel anticancer strategies.</p>
</sec>
<sec disp-level="2" id="s16">
<title>Splicing control defects in neuropathological and muscle-related diseases</title>
<p>As in cancer, pathogenic mechanisms in neurological and muscle-associated diseases can be caused by mutations in genes that affect splicing of their pre-mRNAs, or by mutations that affect the expression and the activity of splicing factors that control splice site utilization. Excellent reviews have recently presented the prevalence of alternative splicing, the role of RBPs, and the functional diversity of splice variants in neuronal systems (<xref ref-type="bibr" rid="bib29">Darnell, 2013</xref>; <xref ref-type="bibr" rid="bib113">Raj and Blencowe, 2015</xref>). Here, we present recent advances that solidify the links between splicing control and neuronal and muscular pathologies (<xref ref-type="fig" rid="fig6">Fig. 6</xref>). Identifying functionally relevant variants and changes in the expression/activity of regulators remains challenging, particularly in neuropathologies. This is mainly a result of tissue availability and heterogeneity, as well as difficulties in developing adequate animal models that recapitulate human phenotypes.</p>
<fig fig-type="figure" id="fig6" orientation="portrait" position="float">
<label>Figure 6.</label>
<caption>
<p>
<bold>Diagram representing some of the defects in the activity, level, and localization of splicing factors linked to the altered production of splice variants in neurological and muscle-associated diseases.</bold>
</p>
</caption>
<graphic xlink:href="JCB_201510032_Fig6"></graphic>
</fig>
</sec>
<sec disp-level="2" id="s17">
<title>ALS and FTD</title>
<p>Although mutations in the splicing regulatory RBP TDP-43 are found in only a fraction of all cases of ALS and FTD, cytoplasmic inclusions and the nuclear depletion of TDP-43 are hallmarks of these diseases (<xref ref-type="bibr" rid="bib61">Janssens and Van Broeckhoven, 2013</xref>; <xref ref-type="bibr" rid="bib121">Scotter et al., 2015</xref>). Decreasing the expression of TDP-43 leads to neuronal defects in mice and affects the alternative splicing of transcripts encoding components important in neuronal development or implicated in neurological diseases (<xref ref-type="bibr" rid="bib106">Polymenidou et al., 2011</xref>; <xref ref-type="bibr" rid="bib136">Tollervey et al., 2011</xref>; <xref ref-type="bibr" rid="bib158">Yang et al., 2014a</xref>). Splicing defects in ALS tissues occur in target TDP-43 transcripts (<xref ref-type="bibr" rid="bib7">Arnold et al., 2013</xref>; <xref ref-type="bibr" rid="bib158">Yang et al., 2014a</xref>). A recent study in mice indicates that a decrease in TDP-43 impairs splicing fidelity and leads to the aberrant inclusion of cryptic exons, an effect also seen in brain tissues from ALS-FTD patients (<xref ref-type="bibr" rid="bib80">Ling et al., 2015</xref>). Similar to TDP-43, mutations and loss of nuclear function of FUS have been linked to alternative splicing changes in ALS, with a few pre-mRNA targets also regulated by TDP-43 (<xref ref-type="bibr" rid="bib71">Lagier-Tourenne et al., 2012</xref>; <xref ref-type="bibr" rid="bib23">Coady and Manley, 2015</xref>). Cytoplasmic aggregates of mutated FUS or TDP-43 often sequester other splicing proteins, and this may also contribute to alterations in splicing profiles. For example, the ability of FUS to interact with U1 snRNP is likely responsible for the U1 snRNP cytoplasmic mislocalization in FUS-mutated ALS patient fibroblasts (<xref ref-type="bibr" rid="bib163">Yu and Reed, 2015</xref>; <xref ref-type="bibr" rid="bib164">Yu et al., 2015</xref>). ALS-associated mutations in hnRNP A1/A2 proteins also cause cytoplasmic aggregation (<xref ref-type="bibr" rid="bib67">Kim et al., 2013</xref>). In several ALS-FTD patients, GGGGCC repeat expansion that promotes G-quadruplex formation in the <italic>C9ORF72</italic> gene sequester splicing factors such as SRSF2 and hnRNP H, which in turn may promote extensive alternative splicing defects and neurodegeneration (<xref ref-type="bibr" rid="bib73">Lee et al., 2013</xref>; <xref ref-type="bibr" rid="bib109">Prudencio et al., 2015</xref>; <xref ref-type="bibr" rid="bib169">Zhang et al., 2015b</xref>). Further studies should clarify whether the pathogenic impact of aggregates is strictly caused by loss of function or whether toxicity associated with aggregate formation also contributes to the clinical manifestation of ALS and FTD.</p>
</sec>
<sec disp-level="2" id="s18">
<title>Alzheimer’s disease (AD) and Huntington’s disease (HD)</title>
<p>The deposition of oligomeric β-amyloid peptides and the formation of neurofibrillary tangles associated with the hyperphosphorylation of the microtubule-associated TAU protein have been implicated in AD (<xref ref-type="bibr" rid="bib60">Ittner and Gotz, 2011</xref>). ApoE4 status is one of the strongest genetic risk factors, and it possibly affects both β-amyloid and neurofibrillary tangle pathologies. Many genes involved in these pathways, including ApoE4, sustain splicing mutations that have been linked to AD or present profiles of alternative splicing that are altered in AD tissues (<xref ref-type="bibr" rid="bib82">Love et al., 2015</xref>). RNA sequencing data suggest considerable alternative splicing abnormalities in AD tissues, including in transcripts encoding presenilin-1 and clusterin (<xref ref-type="bibr" rid="bib9">Bai et al., 2013</xref>). Several splicing factors whose expression are misregulated in AD have been identified, including RBFOX, SR, and hnRNP A1 proteins, whereas splicing components, such as the U1 snRNP, appear to be depleted from the nucleus to form cytoplasmic aggregates (<xref ref-type="bibr" rid="bib9">Bai et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Hales et al., 2014</xref>). Interestingly, a depletion of U1 snRNP components in HEK293 cells disrupts the expression of splice variants encoding the amyloid precursor protein and increases the level of a β-amyloid peptide (<xref ref-type="bibr" rid="bib9">Bai et al., 2013</xref>). HD is caused by expanded CAG repeats in the <italic>HTT</italic> gene that promote missplicing of its transcripts (<xref ref-type="bibr" rid="bib118">Sathasivam et al., 2013</xref>). The CAG repeats may also sequester splicing factors eliciting alternative splicing defects in other transcripts (<xref ref-type="bibr" rid="bib93">Mykowska et al., 2011</xref>). Like individuals suffering from FTD, HD subjects display an imbalance in the production of TAU variants that promote deposits. Human HD tissues and a mouse model of HD show alterations in the expression of SRSF6, which may modulate <italic>TAU</italic> splicing, leading to TAU variants with a greater propensity to form deposits (<xref ref-type="bibr" rid="bib161">Yin et al., 2012</xref>; <xref ref-type="bibr" rid="bib39">Fernández-Nogales et al., 2014</xref>).</p>
</sec>
<sec disp-level="2" id="s19">
<title>Schizophrenia (SZ)</title>
<p>SZ is a complex neuronal disease promoting brain dysfunction. A variety of alternative splicing anomalies have been described in the brain or neuronal subtypes of SZ patients, including transcripts encoding a glutamate transporter (EAAT; <xref ref-type="bibr" rid="bib98">O’Donovan et al., 2015</xref>) and microcephalin (MCPH1; <xref ref-type="bibr" rid="bib99">Oldmeadow et al., 2014</xref>). A polymorphism associated with an increased risk of SZ occurs in the dopamine receptor gene <italic>DRD2</italic> and affects the ability of the splicing regulator ZRANB2 to control alternative splicing of <italic>DRD2</italic> transcripts (<xref ref-type="bibr" rid="bib24">Cohen et al., 2015</xref>). The lncRNA gomafu, which is down-regulated in the gray matter from the superior temporal gyrus of SZ patients, is bound by the splicing regulators QKI and SRSF1 to control the alternative splicing of transcripts implicated in SZ (<xref ref-type="bibr" rid="bib11">Barry et al., 2014</xref>). Other lncRNAs have been associated with neuronal stem cell differentiation and the control of alternative splicing through interaction with the neuronal splicing factor PTBP1 (<xref ref-type="bibr" rid="bib114">Ramos et al., 2015</xref>). However, although changes in the expression of lncRNAs involved in epigenetic modifications have been linked to neuronal diseases, their contribution to alternative splicing control remains to be examined (<xref ref-type="bibr" rid="bib115">Roberts et al., 2014</xref>).</p>
</sec>
<sec disp-level="2" id="s20">
<title>Autism spectrum disorder (ASD)</title>
<p>Mutations in, or altered expression of, &gt;100 genes have been linked to ASD (<xref ref-type="bibr" rid="bib34">Devlin and Scherer, 2012</xref>; <xref ref-type="bibr" rid="bib27">Corominas et al., 2014</xref>). The majority of these genes produce splice variants, and recurrent splicing defects in some of them have been noted in autistic individuals (<xref ref-type="bibr" rid="bib147">Voineagu et al., 2011</xref>; <xref ref-type="bibr" rid="bib27">Corominas et al., 2014</xref>). RBFOX proteins play a critical role in brain development and function (<xref ref-type="bibr" rid="bib43">Gehman et al., 2011</xref>, <xref ref-type="bibr" rid="bib44">2012</xref>), and RBFOX1 haploinsufficiency has been implicated in a variety of neuropsychiatric disorders including ASD (<xref ref-type="bibr" rid="bib147">Voineagu et al., 2011</xref>). In the mouse brain, the depletion of RBFOX proteins alters the alternative splicing of transcripts implicated in ASD (<xref ref-type="bibr" rid="bib153">Weyn-Vanhentenryck et al., 2014</xref>). Identification of a clinically relevant set of splicing events remains challenging because RBFOX proteins affect other pathways in RNA processing and in transcription. Moreover, three highly related RBFOX proteins with partially overlapping functions are expressed in the brain. A recent study has identified a highly dynamic set of microexons (3–15 nucleotides in size) in transcripts of different neurofunctional categories that are misregulated in the brain of autistic individuals. Several neural microexons affect protein–protein interactions that are crucial for neural function, and many are controlled by the splicing regulator nSR100, whose expression is important for normal nervous system development (<xref ref-type="bibr" rid="bib112">Quesnel-Vallières et al., 2015</xref>) and is reported to be reduced in autistic brain tissues (<xref ref-type="bibr" rid="bib59">Irimia et al., 2014</xref>). Neural microexon splicing is also regulated by the PTBP1 and RBFOX proteins (<xref ref-type="bibr" rid="bib78">Li et al., 2015</xref>) that are critical for normal neuronal function (<xref ref-type="bibr" rid="bib44">Gehman et al., 2012</xref>; <xref ref-type="bibr" rid="bib79">Licatalosi et al., 2012</xref>; <xref ref-type="bibr" rid="bib76">Li et al., 2014</xref>). Because microexons have also been linked to SZ and epilepsy, it will be most revealing to characterize the molecular pathways that regulate their inclusion in these neurological disorders.</p>
</sec>
<sec disp-level="2" id="s21">
<title>SMA</title>
<p>Mutations that reduce the level of SMN proteins, which are involved in snRNP biogenesis, cause SMA. Although multiple alternative splicing defects have been noted, it remains unclear which splicing abnormalities cause the human phenotypes (<xref ref-type="bibr" rid="bib140">Ule et al., 2005</xref>; <xref ref-type="bibr" rid="bib170">Zhang et al., 2008</xref>, <xref ref-type="bibr" rid="bib171">2013</xref>; <xref ref-type="bibr" rid="bib40">Fogel et al., 2012</xref>; <xref ref-type="bibr" rid="bib55">Highley et al., 2014</xref>). As the SMN protein deficiency can be rescued by stimulating exon 7 inclusion in the <italic>SMN2</italic> pre-mRNA, efforts deployed to achieve this goal in mouse models have produced encouraging results using oligonucleotides that block the activity of an intron splicing silencer (<xref ref-type="bibr" rid="bib57">Hua et al., 2015</xref>; <xref ref-type="bibr" rid="bib130">Staropoli et al., 2015</xref>) or small molecules that stimulate exon 7 inclusion with apparent high specificity (<xref ref-type="bibr" rid="bib96">Naryshkin et al., 2014</xref>; <xref ref-type="bibr" rid="bib103">Palacino et al., 2015</xref>).</p>
</sec>
<sec disp-level="2" id="s22">
<title>Heart disease</title>
<p>Mutations that truncate the sarcomeric protein titin cause dilated cardiomyopathy (<xref ref-type="bibr" rid="bib54">Herman et al., 2012</xref>). A loss-of-function mutation in RBM20 affects the alternative splicing of <italic>titin</italic>, causing dilated cardiomyopathy (<xref ref-type="bibr" rid="bib51">Guo et al., 2012</xref>). Hypoxic conditions associated with cardiac hypertrophy activate the expression of SF3B1, which in turn induces the production of a splice variant of ketohexokinase associated with contractile dysfunction (<xref ref-type="bibr" rid="bib92">Mirtschink et al., 2015</xref>).</p>
</sec>
<sec disp-level="2" id="s23">
<title>Advances and challenges in monitoring disease-associated changes in alternative splicing</title>
<p>Today, it is very clear that cells derived from patients with a variety of diseases display splicing defects, with studies relating to cancer and neuropathologies being the most prevalent. These splicing alterations may generate recognizable signatures that can guide diagnostics and may lead to the identification of new therapeutic targets. This important cataloguing effort is now increasing through genome-wide studies that exploit affordable RNA sequencing technologies and access to sequence repositories. Bioinformatic resources designed to interrogate these data are also expanding and are becoming widely available (<xref ref-type="bibr" rid="bib134">Tang et al., 2013</xref>; <xref ref-type="bibr" rid="bib122">Sebestyén et al., 2015</xref>; Hollander, D., and Ast, G., personal communication).</p>
<p>The reliable identification of targets that support actionable therapeutic approaches is challenged by the fact that correlations are often derived from heterogeneous clinical samples. Moreover, although documentation of the functional impact of splice variants is accumulating (<xref ref-type="bibr" rid="bib64">Kelemen et al., 2013</xref>; <xref ref-type="bibr" rid="bib102">Pagliarini et al., 2015</xref>), the causal contribution of disease-associated splice variants to the disease remains unknown in most cases. The functional assessment of a continuously expanding list of splice variants is an experimentally daunting task, possibly explaining why recent studies have restricted their analysis to mRNA variants encoding proteins with known distinct activities or with premature stop codons that decrease protein production.</p>
<p>To understand the molecular mechanisms that lead to splicing alterations, it will be important to (a) assess the expression, posttranslational modifications, or mutations of splicing regulators and chromatin-modifying components; (b) profile the binding sites of the putative regulatory RBP on target pre-mRNAs in relevant tissue cells as was originally done for NOVA, whose inactivation causes paraneoplastic neurological disorders (<xref ref-type="bibr" rid="bib167">Zhang et al., 2010</xref>); and (c) sequence the genome of diseased and normal tissues for each patient to identity somatic mutations that may contribute to splicing alterations. This comparison is especially relevant to cancer in which genomes are often intrinsically unstable. Moreover, in light of the model proposed earlier, defects in the activity or levels of splicing factors may lead to R loop–mediated mutations that may have a permanent impact on alternative splicing.</p>
<p>To accommodate the analyses of this vast quantity of data, robust computational methods are being developed to link the production of recurrent variants with changes in RBPs (<xref ref-type="bibr" rid="bib122">Sebestyén et al., 2015</xref>). Alternatively, combining large-scale collections of molecular interaction datasets (protein–DNA, protein–RNA, and protein–protein) with cancer transcriptome datasets may reveal regulatory pathways relevant to cancer (Hollander, D., and Ast, G., personal communication). Putative connections can then be validated experimentally or confirmed, for example by using The Cancer Genome Atlas. These emerging procedures justify the usefulness of network-based approaches (<xref ref-type="bibr" rid="bib160">Yang et al., 2014b</xref>) to capture molecular relationships across different regulatory layers that become compromised or that emerge during diseases.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Nancy Greenbaum and Raymund Wellinger for thoughtful comments on the manuscript. We thank Gil Ast and Dror Hollander for sharing results before publication. We apologize to colleagues whose work could not be cited because of space constraints.</p>
<p>We acknowledge support from the Canadian Institutes of Health Research. B. Chabot is the Pierre C. Fournier Research Chair in Functional Genomics at Université de Sherbrooke.</p>
<p>The authors declare no competing financial interests.</p>
</ack>
<fn-group>
<fn id="fnd0e14182">
<p>
<def-list><title>Abbreviations used in this paper:</title><def-item><term>AD</term><def><p>Alzheimer’s disease</p></def></def-item><def-item><term>ALS</term><def><p>amyotrophic lateral sclerosis</p></def></def-item><def-item><term>AML</term><def><p>acute myeloid leukemia</p></def></def-item><def-item><term>ASD</term><def><p>autism spectrum disorder</p></def></def-item><def-item><term>DDR</term><def><p>DNA damage response</p></def></def-item><def-item><term>EMT</term><def><p>epithelial–mesenchymal transition</p></def></def-item><def-item><term>FTD</term><def><p>frontotemporal dementia</p></def></def-item><def-item><term>HD</term><def><p>Huntington’s disease</p></def></def-item><def-item><term>hnRNP</term><def><p>heterogeneous nuclear RNP</p></def></def-item><def-item><term>lncRNA</term><def><p>long noncoding RNA</p></def></def-item><def-item><term>MDS</term><def><p>myelodysplastic syndromes</p></def></def-item><def-item><term>RBP</term><def><p>RNA-binding protein</p></def></def-item><def-item><term>SMA</term><def><p>spinal muscular atrophy</p></def></def-item><def-item><term>snRNP</term><def><p>small nuclear RNP</p></def></def-item><def-item><term>SNV</term><def><p>single-nucleotide variation</p></def></def-item><def-item><term>SR</term><def><p>serine arginine</p></def></def-item><def-item><term>SZ</term><def><p>schizophrenia</p></def></def-item></def-list>
</p>
</fn>
</fn-group>
<ref-list>
<ref id="bib1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adesso</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Calabretta</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Barbagallo</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Capurso</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Pilozzi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Geremia</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Delle Fave</surname><given-names>G.</given-names></name>, and <name name-style="western"><surname>Sette</surname><given-names>C.</given-names></name></person-group>
<year>2013</year>
<article-title>Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway</article-title>. <source/>Oncogene.
<volume>32</volume>:<fpage>2848</fpage>–<lpage>2857</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2012.306</pub-id><pub-id pub-id-type="pmid">22797067</pub-id></mixed-citation>
</ref>
<ref id="bib2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adler</surname><given-names>A.S.</given-names></name>, <name name-style="western"><surname>McCleland</surname><given-names>M.L.</given-names></name>, <name name-style="western"><surname>Yee</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yaylaoglu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hussain</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Cosino</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Quinones</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Modrusan</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Seshagiri</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>E.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth</article-title>. <source/>Genes Dev.
<volume>28</volume>:<fpage>1068</fpage>–<lpage>1084</lpage>. <pub-id pub-id-type="doi">10.1101/gad.237206.113</pub-id><pub-id pub-id-type="pmid">24788092</pub-id></mixed-citation>
</ref>
<ref id="bib3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alló</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Buggiano</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Fededa</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Petrillo</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Schor</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>de la Mata</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Agirre</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Plass</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Eyras</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Elela</surname><given-names>S.A.</given-names></name>, <etal></etal></person-group>
<year>2009</year>
<article-title>Control of alternative splicing through siRNA-mediated transcriptional gene silencing</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>16</volume>:<fpage>717</fpage>–<lpage>724</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.1620</pub-id><pub-id pub-id-type="pmid">19543290</pub-id></mixed-citation>
</ref>
<ref id="bib4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ameyar-Zazoua</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rachez</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Souidi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Robin</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Fritsch</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Morozova</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Fenouil</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Descostes</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Andrau</surname><given-names>J.C.</given-names></name>, <etal></etal></person-group>
<year>2012</year>
<article-title>Argonaute proteins couple chromatin silencing to alternative splicing</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>19</volume>:<fpage>998</fpage>–<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2373</pub-id><pub-id pub-id-type="pmid">22961379</pub-id></mixed-citation>
</ref>
<ref id="bib5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anczuków</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Rosenberg</surname><given-names>A.Z.</given-names></name>, <name name-style="western"><surname>Akerman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zhan</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Karni</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Muthuswamy</surname><given-names>S.K.</given-names></name>, and <name name-style="western"><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group>
<year>2012</year>
<article-title>The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>19</volume>:<fpage>220</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2207</pub-id><pub-id pub-id-type="pmid">22245967</pub-id></mixed-citation>
</ref>
<ref id="bib6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anczuków</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Akerman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Clery</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Shirole</surname><given-names>N.H.</given-names></name>, <name name-style="western"><surname>Raimer</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Hua</surname><given-names>Y.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>SRSF1-regulated alternative splicing in breast cancer</article-title>. <source/>Mol. Cell.
<volume>60</volume>:<fpage>105</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2015.09.005</pub-id><pub-id pub-id-type="pmid">26431027</pub-id></mixed-citation>
</ref>
<ref id="bib7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnold</surname><given-names>E.S.</given-names></name>, <name name-style="western"><surname>Ling</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Huelga</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Lagier-Tourenne</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Polymenidou</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ditsworth</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Kordasiewicz</surname><given-names>H.B.</given-names></name>, <name name-style="western"><surname>McAlonis-Downes</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Platoshyn</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Parone</surname><given-names>P.A.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>110</volume>:<fpage>E736</fpage>–<lpage>E745</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1222809110</pub-id><pub-id pub-id-type="pmid">23382207</pub-id></mixed-citation>
</ref>
<ref id="bib8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babic</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>E.S.</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Masui</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Villa</surname><given-names>G.R.</given-names></name>, <name name-style="western"><surname>Akhavan</surname><given-names>D.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer</article-title>. <source/>Cell Metab.
<volume>17</volume>:<fpage>1000</fpage>–<lpage>1008</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2013.04.013</pub-id><pub-id pub-id-type="pmid">23707073</pub-id></mixed-citation>
</ref>
<ref id="bib9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Hales</surname><given-names>C.M.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>P.C.</given-names></name>, <name name-style="western"><surname>Gozal</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Dammer</surname><given-names>E.B.</given-names></name>, <name name-style="western"><surname>Fritz</surname><given-names>J.J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Duong</surname><given-names>D.M.</given-names></name>, <name name-style="western"><surname>Street</surname><given-names>C.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>110</volume>:<fpage>16562</fpage>–<lpage>16567</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1310249110</pub-id><pub-id pub-id-type="pmid">24023061</pub-id></mixed-citation>
</ref>
<ref id="bib10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barash</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Calarco</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Shai</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Blencowe</surname><given-names>B.J.</given-names></name>, and <name name-style="western"><surname>Frey</surname><given-names>B.J.</given-names></name></person-group>
<year>2010</year>
<article-title>Deciphering the splicing code</article-title>. <source/>Nature.
<volume>465</volume>:<fpage>53</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1038/nature09000</pub-id><pub-id pub-id-type="pmid">20445623</pub-id></mixed-citation>
</ref>
<ref id="bib11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barry</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Briggs</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Vanichkina</surname><given-names>D.P.</given-names></name>, <name name-style="western"><surname>Poth</surname><given-names>E.M.</given-names></name>, <name name-style="western"><surname>Beveridge</surname><given-names>N.J.</given-names></name>, <name name-style="western"><surname>Ratnu</surname><given-names>V.S.</given-names></name>, <name name-style="western"><surname>Nayler</surname><given-names>S.P.</given-names></name>, <name name-style="western"><surname>Nones</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bredy</surname><given-names>T.W.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing</article-title>. <source/>Mol. Psychiatry.
<volume>19</volume>:<fpage>486</fpage>–<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.45</pub-id><pub-id pub-id-type="pmid">23628989</pub-id></mixed-citation>
</ref>
<ref id="bib12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Batra</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Charizanis</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Manchanda</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mohan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Finn</surname><given-names>D.J.</given-names></name>, <name name-style="western"><surname>Goodwin</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sobczak</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Thornton</surname><given-names>C.A.</given-names></name>, and <name name-style="western"><surname>Swanson</surname><given-names>M.S.</given-names></name></person-group>
<year>2014</year>
<article-title>Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease</article-title>. <source/>Mol. Cell.
<volume>56</volume>:<fpage>311</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2014.08.027</pub-id><pub-id pub-id-type="pmid">25263597</pub-id></mixed-citation>
</ref>
<ref id="bib13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bentley</surname><given-names>D.L.</given-names></name></person-group>
<year>2014</year>
<article-title>Coupling mRNA processing with transcription in time and space</article-title>. <source/>Nat. Rev. Genet.
<volume>15</volume>:<fpage>163</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3662</pub-id><pub-id pub-id-type="pmid">24514444</pub-id></mixed-citation>
</ref>
<ref id="bib14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biamonti</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Catillo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pignataro</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Montecucco</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>Ghigna</surname><given-names>C.</given-names></name></person-group>
<year>2014</year>
<article-title>The alternative splicing side of cancer</article-title>. <source/>Semin. Cell Dev. Biol.
<volume>32</volume>:<fpage>30</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2014.03.016</pub-id><pub-id pub-id-type="pmid">24657195</pub-id></mixed-citation>
</ref>
<ref id="bib15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boultwood</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Dolatshad</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Varanasi</surname><given-names>S.S.</given-names></name>, <name name-style="western"><surname>Yip</surname><given-names>B.H.</given-names></name>, and <name name-style="western"><surname>Pellagatti</surname><given-names>A.</given-names></name></person-group>
<year>2014</year>
<article-title>The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes</article-title>. <source/>Adv. Biol. Regul.
<volume>54</volume>:<fpage>153</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbior.2013.09.005</pub-id><pub-id pub-id-type="pmid">24080589</pub-id></mixed-citation>
</ref>
<ref id="bib16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braeutigam</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Rago</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Rolke</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Waldmeier</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Christofori</surname><given-names>G.</given-names></name>, and <name name-style="western"><surname>Winter</surname><given-names>J.</given-names></name></person-group>
<year>2014</year>
<article-title>The RNA-binding protein Rbfox2: An essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion</article-title>. <source/>Oncogene.
<volume>33</volume>:<fpage>1082</fpage>–<lpage>1092</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2013.50</pub-id><pub-id pub-id-type="pmid">23435423</pub-id></mixed-citation>
</ref>
<ref id="bib17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brooks</surname><given-names>A.N.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>P.S.</given-names></name>, <name name-style="western"><surname>de Waal</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Sharifnia</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Imielinski</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Saksena</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Pedamallu</surname><given-names>C.S.</given-names></name>, <name name-style="western"><surname>Sivachenko</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Rosenberg</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Chmielecki</surname><given-names>J.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>A pan-cancer analysis of transcriptome changes associated with somatic mutations in <italic>U2AF1</italic> reveals commonly altered splicing events</article-title>. <source/>PLoS One.
<volume>9</volume>:<fpage>e87361</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0087361</pub-id><pub-id pub-id-type="pmid">24498085</pub-id></mixed-citation>
</ref>
<ref id="bib18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calabretta</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bielli</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Passacantilli</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Pilozzi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Fendrich</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Capurso</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Fave</surname><given-names>G.D.</given-names></name>, and <name name-style="western"><surname>Sette</surname><given-names>C.</given-names></name></person-group>
<year>2015</year>
<article-title>Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells</article-title>. <source/>Oncogene. In press. <pub-id pub-id-type="doi">10.1038/onc.2015.270</pub-id></mixed-citation>
</ref>
<ref id="bib19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charizanis</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>K.Y.</given-names></name>, <name name-style="western"><surname>Batra</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Goodwin</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shiue</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Cline</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Scotti</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>G.</given-names></name>, <etal></etal></person-group>
<year>2012</year>
<article-title>Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy</article-title>. <source/>Neuron.
<volume>75</volume>:<fpage>437</fpage>–<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.05.029</pub-id><pub-id pub-id-type="pmid">22884328</pub-id></mixed-citation>
</ref>
<ref id="bib20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chasin</surname><given-names>L.A.</given-names></name></person-group>
<year>2007</year>
<article-title>Searching for splicing motifs</article-title>. <source/>Adv. Exp. Med. Biol.
<volume>623</volume>:<fpage>85</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1007/978-0-387-77374-2_6</pub-id><pub-id pub-id-type="pmid">18380342</pub-id></mixed-citation>
</ref>
<ref id="bib21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christofk</surname><given-names>H.R.</given-names></name>, <name name-style="western"><surname>Vander Heiden</surname><given-names>M.G.</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Ramanathan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gerszten</surname><given-names>R.E.</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Fleming</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Schreiber</surname><given-names>S.L.</given-names></name>, and <name name-style="western"><surname>Cantley</surname><given-names>L.C.</given-names></name></person-group>
<year>2008</year>
<article-title>The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth</article-title>. <source/>Nature.
<volume>452</volume>:<fpage>230</fpage>–<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1038/nature06734</pub-id><pub-id pub-id-type="pmid">18337823</pub-id></mixed-citation>
</ref>
<ref id="bib22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cieply</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Carstens</surname><given-names>R.P.</given-names></name></person-group>
<year>2015</year>
<article-title>Functional roles of alternative splicing factors in human disease</article-title>. <source/>Wiley Interdiscip. Rev. RNA.
<volume>6</volume>:<fpage>311</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1002/wrna.1276</pub-id><pub-id pub-id-type="pmid">25630614</pub-id></mixed-citation>
</ref>
<ref id="bib23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coady</surname><given-names>T.H.</given-names></name>, and <name name-style="western"><surname>Manley</surname><given-names>J.L.</given-names></name></person-group>
<year>2015</year>
<article-title>ALS mutations in TLS/FUS disrupt target gene expression</article-title>. <source/>Genes Dev.
<volume>29</volume>:<fpage>1696</fpage>–<lpage>1706</lpage>. <pub-id pub-id-type="doi">10.1101/gad.267286.115</pub-id><pub-id pub-id-type="pmid">26251528</pub-id></mixed-citation>
</ref>
<ref id="bib24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>O.S.</given-names></name>, <name name-style="western"><surname>Weickert</surname><given-names>T.W.</given-names></name>, <name name-style="western"><surname>Hess</surname><given-names>J.L.</given-names></name>, <name name-style="western"><surname>Paish</surname><given-names>L.M.</given-names></name>, <name name-style="western"><surname>McCoy</surname><given-names>S.Y.</given-names></name>, <name name-style="western"><surname>Rothmond</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Galletly</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Weinberg</surname><given-names>D.D.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>X.F.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>A splicing-regulatory polymorphism in <italic>DRD2</italic> disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples</article-title>. <source/>Mol. Psychiatry. In press. <pub-id pub-id-type="doi">10.1038/mp.2015.137</pub-id></mixed-citation>
</ref>
<ref id="bib25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colla</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ong</surname><given-names>D.S.</given-names></name>, <name name-style="western"><surname>Ogoti</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Marchesini</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mistry</surname><given-names>N.A.</given-names></name>, <name name-style="western"><surname>Clise-Dwyer</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ang</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Storti</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Viale</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Giuliani</surname><given-names>N.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome</article-title>. <source/>Cancer Cell.
<volume>27</volume>:<fpage>644</fpage>–<lpage>657</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccell.2015.04.007</pub-id><pub-id pub-id-type="pmid">25965571</pub-id></mixed-citation>
</ref>
<ref id="bib26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Comiskey</surname><given-names>D.F.</given-names><suffix>Jr</suffix></name>., <name name-style="western"><surname>Jacob</surname><given-names>A.G.</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>R.K.</given-names></name>, <name name-style="western"><surname>Tapia-Santos</surname><given-names>A.S.</given-names></name>, and <name name-style="western"><surname>Chandler</surname><given-names>D.S.</given-names></name></person-group>
<year>2015</year>
<article-title>Splicing factor SRSF1 negatively regulates alternative splicing of <italic>MDM2</italic> under damage</article-title>. <source/>Nucleic Acids Res.
<volume>43</volume>:<fpage>4202</fpage>–<lpage>4218</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv223</pub-id><pub-id pub-id-type="pmid">25845590</pub-id></mixed-citation>
</ref>
<ref id="bib27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corominas</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>G.N.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ghamsari</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Broly</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rodriguez</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tam</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Trigg</surname><given-names>S.A.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism</article-title>. <source/>Nat. Commun.
<volume>5</volume>:<fpage>3650</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms4650</pub-id><pub-id pub-id-type="pmid">24722188</pub-id></mixed-citation>
</ref>
<ref id="bib28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corrionero</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Minana</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Valcarcel</surname><given-names>J.</given-names></name></person-group>
<year>2011</year>
<article-title>Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A</article-title>. <source/>Genes Dev.
<volume>25</volume>:<fpage>445</fpage>–<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1101/gad.2014311</pub-id><pub-id pub-id-type="pmid">21363963</pub-id></mixed-citation>
</ref>
<ref id="bib29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Darnell</surname><given-names>R.B.</given-names></name></person-group>
<year>2013</year>
<article-title>RNA protein interaction in neurons</article-title>. <source/>Annu. Rev. Neurosci.
<volume>36</volume>:<fpage>243</fpage>–<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-062912-114322</pub-id><pub-id pub-id-type="pmid">23701460</pub-id></mixed-citation>
</ref>
<ref id="bib30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Das</surname><given-names>S.</given-names></name>, and <name name-style="western"><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group>
<year>2014</year>
<article-title>Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer.</article-title>
<source/>Mol. Cancer Res.
<volume>12</volume>:<fpage>1195</fpage>–<lpage>1204</lpage>. <pub-id pub-id-type="doi">10.1158/1541-7786.MCR-14-0131</pub-id><pub-id pub-id-type="pmid">24807918</pub-id></mixed-citation>
</ref>
<ref id="bib31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>David</surname><given-names>C.J.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Assanah</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Canoll</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Manley</surname><given-names>J.L.</given-names></name></person-group>
<year>2010</year>
<article-title>HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer</article-title>. <source/>Nature.
<volume>463</volume>:<fpage>364</fpage>–<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1038/nature08697</pub-id><pub-id pub-id-type="pmid">20010808</pub-id></mixed-citation>
</ref>
<ref id="bib32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davidson</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kerr</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>West</surname><given-names>S.</given-names></name></person-group>
<year>2012</year>
<article-title>Co-transcriptional degradation of aberrant pre-mRNA by Xrn2</article-title>. <source/>EMBO J.
<volume>31</volume>:<fpage>2566</fpage>–<lpage>2578</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2012.101</pub-id><pub-id pub-id-type="pmid">22522706</pub-id></mixed-citation>
</ref>
<ref id="bib33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeOcesano-Pereira</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Amaral</surname><given-names>M.S.</given-names></name>, <name name-style="western"><surname>Parreira</surname><given-names>K.S.</given-names></name>, <name name-style="western"><surname>Ayupe</surname><given-names>A.C.</given-names></name>, <name name-style="western"><surname>Jacysyn</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Amarante-Mendes</surname><given-names>G.P.</given-names></name>, <name name-style="western"><surname>Reis</surname><given-names>E.M.</given-names></name>, and <name name-style="western"><surname>Verjovski-Almeida</surname><given-names>S.</given-names></name></person-group>
<year>2014</year>
<article-title>Long non-coding RNA <italic>INXS</italic> is a critical mediator of BCL-XS induced apoptosis</article-title>. <source/>Nucleic Acids Res.
<volume>42</volume>:<fpage>8343</fpage>–<lpage>8355</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku561</pub-id><pub-id pub-id-type="pmid">24992962</pub-id></mixed-citation>
</ref>
<ref id="bib34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Devlin</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Scherer</surname><given-names>S.W.</given-names></name></person-group>
<year>2012</year>
<article-title>Genetic architecture in autism spectrum disorder</article-title>. <source/>Curr. Opin. Genet. Dev.
<volume>22</volume>:<fpage>229</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2012.03.002</pub-id><pub-id pub-id-type="pmid">22463983</pub-id></mixed-citation>
</ref>
<ref id="bib35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Modugno</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Demonte</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Balsamo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bronzi</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Nicotra</surname><given-names>M.R.</given-names></name>, <name name-style="western"><surname>Alessio</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jager</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Condeelis</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Santoni</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Natali</surname><given-names>P.G.</given-names></name>, and <name name-style="western"><surname>Nistico</surname><given-names>P.</given-names></name></person-group>
<year>2007</year>
<article-title>Molecular cloning of hMena (ENAH) and its splice variant hMena<sup>+11a</sup>: Epidermal growth factor increases their expression and stimulates hMena<sup>+11a</sup> phosphorylation in breast cancer cell lines</article-title>. <source/>Cancer Res.
<volume>67</volume>:<fpage>2657</fpage>–<lpage>2665</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-1997</pub-id><pub-id pub-id-type="pmid">17363586</pub-id></mixed-citation>
</ref>
<ref id="bib36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dolatshad</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Pellagatti</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fernandez-Mercado</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yip</surname><given-names>B.H.</given-names></name>, <name name-style="western"><surname>Malcovati</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Attwood</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Przychodzen</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Sahgal</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Kanapin</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Lockstone</surname><given-names>H.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells</article-title>. <source/>Leukemia.
<volume>29</volume>:<fpage>1092</fpage>–<lpage>1103</lpage>. <pub-id pub-id-type="doi">10.1038/leu.2014.331</pub-id><pub-id pub-id-type="pmid">25428262</pub-id></mixed-citation>
</ref>
<ref id="bib37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Domínguez-Sánchez</surname><given-names>M.S.</given-names></name>, <name name-style="western"><surname>Barroso</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gomez-Gonzalez</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Luna</surname><given-names>R.</given-names></name>, and <name name-style="western"><surname>Aguilera</surname><given-names>A.</given-names></name></person-group>
<year>2011</year>
<article-title>Genome instability and transcription elongation impairment in human cells depleted of THO/TREX</article-title>. <source/>PLoS Genet.
<volume>7</volume>:<fpage>e1002386</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002386</pub-id><pub-id pub-id-type="pmid">22144908</pub-id></mixed-citation>
</ref>
<ref id="bib38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Echeverria</surname><given-names>G.V.</given-names></name>, and <name name-style="western"><surname>Cooper</surname><given-names>T.A.</given-names></name></person-group>
<year>2012</year>
<article-title>RNA-binding proteins in microsatellite expansion disorders: Mediators of RNA toxicity</article-title>. <source/>Brain Res.
<volume>1462</volume>:<fpage>100</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.02.030</pub-id><pub-id pub-id-type="pmid">22405728</pub-id></mixed-citation>
</ref>
<ref id="bib39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernández-Nogales</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cabrera</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Santos-Galindo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hoozemans</surname><given-names>J.J.</given-names></name>, <name name-style="western"><surname>Ferrer</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Rozemuller</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Avila</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Lucas</surname><given-names>J.J.</given-names></name></person-group>
<year>2014</year>
<article-title>Huntington’s disease is a four-repeat tauopathy with tau nuclear rods</article-title>. <source/>Nat. Med.
<volume>20</volume>:<fpage>881</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3617</pub-id><pub-id pub-id-type="pmid">25038828</pub-id></mixed-citation>
</ref>
<ref id="bib40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fogel</surname><given-names>B.L.</given-names></name>, <name name-style="western"><surname>Wexler</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Wahnich</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Friedrich</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Vijayendran</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Parikshak</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Konopka</surname><given-names>G.</given-names></name>, and <name name-style="western"><surname>Geschwind</surname><given-names>D.H.</given-names></name></person-group>
<year>2012</year>
<article-title>RBFOX1 regulates both splicing and transcriptional networks in human neuronal development</article-title>. <source/>Hum. Mol. Genet.
<volume>21</volume>:<fpage>4171</fpage>–<lpage>4186</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds240</pub-id><pub-id pub-id-type="pmid">22730494</pub-id></mixed-citation>
</ref>
<ref id="bib41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>X.D.</given-names></name>, and <name name-style="western"><surname>Ares</surname><given-names>M.</given-names><suffix>Jr</suffix></name></person-group>
<year>2014</year>
<article-title>Context-dependent control of alternative splicing by RNA-binding proteins</article-title>. <source/>Nat. Rev. Genet.
<volume>15</volume>:<fpage>689</fpage>–<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3778</pub-id><pub-id pub-id-type="pmid">25112293</pub-id></mixed-citation>
</ref>
<ref id="bib42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ge</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>DuHadaway</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Herlyn</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rodeck</surname><given-names>U.</given-names></name>, and <name name-style="western"><surname>Prendergast</surname><given-names>G.C.</given-names></name></person-group>
<year>1999</year>
<article-title>Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>96</volume>:<fpage>9689</fpage>–<lpage>9694</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.17.9689</pub-id><pub-id pub-id-type="pmid">10449755</pub-id></mixed-citation>
</ref>
<ref id="bib43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gehman</surname><given-names>L.T.</given-names></name>, <name name-style="western"><surname>Stoilov</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Maguire</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Damianov</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>C.H.</given-names></name>, <name name-style="western"><surname>Shiue</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Ares</surname><given-names>M.</given-names><suffix>Jr</suffix></name>., <name name-style="western"><surname>Mody</surname><given-names>I.</given-names></name>, and <name name-style="western"><surname>Black</surname><given-names>D.L.</given-names></name></person-group>
<year>2011</year>
<article-title>The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain</article-title>. <source/>Nat. Genet.
<volume>43</volume>:<fpage>706</fpage>–<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1038/ng.841</pub-id><pub-id pub-id-type="pmid">21623373</pub-id></mixed-citation>
</ref>
<ref id="bib44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gehman</surname><given-names>L.T.</given-names></name>, <name name-style="western"><surname>Meera</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Stoilov</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Shiue</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>O’Brien</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Meisler</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Ares</surname><given-names>M.</given-names><suffix>Jr</suffix></name>., <name name-style="western"><surname>Otis</surname><given-names>T.S.</given-names></name>, and <name name-style="western"><surname>Black</surname><given-names>D.L.</given-names></name></person-group>
<year>2012</year>
<article-title>The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function</article-title>. <source/>Genes Dev.
<volume>26</volume>:<fpage>445</fpage>–<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1101/gad.182477.111</pub-id><pub-id pub-id-type="pmid">22357600</pub-id></mixed-citation>
</ref>
<ref id="bib45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gentien</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Kosmider</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Nguyen-Khac</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Albaud</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Rapinat</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dumont</surname><given-names>A.G.</given-names></name>, <name name-style="western"><surname>Damm</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Popova</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Marais</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Fontenay</surname><given-names>M.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>A common alternative splicing signature is associated with SF3B1 mutations in malignancies from different cell lineages</article-title>. <source/>Leukemia.
<volume>28</volume>:<fpage>1355</fpage>–<lpage>1357</lpage>. <pub-id pub-id-type="doi">10.1038/leu.2014.28</pub-id><pub-id pub-id-type="pmid">24434863</pub-id></mixed-citation>
</ref>
<ref id="bib46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gerstberger</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hafner</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Tuschl</surname><given-names>T.</given-names></name></person-group>
<year>2014</year>
<article-title>A census of human RNA-binding proteins</article-title>. <source/>Nat. Rev. Genet.
<volume>15</volume>:<fpage>829</fpage>–<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3813</pub-id><pub-id pub-id-type="pmid">25365966</pub-id></mixed-citation>
</ref>
<ref id="bib47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzalez</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Munita</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Agirre</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Dittmer</surname><given-names>T.A.</given-names></name>, <name name-style="western"><surname>Gysling</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Misteli</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Luco</surname><given-names>R.F.</given-names></name></person-group>
<year>2015</year>
<article-title>A lncRNA regulates alternative splicing via establishment of a splicing-specific chromatin signature</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>22</volume>:<fpage>370</fpage>–<lpage>376</lpage>.<pub-id pub-id-type="pmid">25849144</pub-id></mixed-citation>
</ref>
<ref id="bib48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodwin</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mohan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Batra</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>K.Y.</given-names></name>, <name name-style="western"><surname>Charizanis</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Gomez</surname><given-names>F.J.</given-names></name>, <name name-style="western"><surname>Eddarkaoui</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sergeant</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Buee</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kimura</surname><given-names>T.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>MBNL sequestration by toxic RNAs and RNA misprocessing in the myotonic dystrophy brain</article-title>. <source/>Cell Reports.
<volume>12</volume>:<fpage>1159</fpage>–<lpage>1168</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.07.029</pub-id><pub-id pub-id-type="pmid">26257173</pub-id></mixed-citation>
</ref>
<ref id="bib49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graubert</surname><given-names>T.A.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Okeyo-Owuor</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Lunn</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Krysiak</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>C.C.</given-names></name>, <name name-style="western"><surname>Koboldt</surname><given-names>D.C.</given-names></name>, <name name-style="western"><surname>Larson</surname><given-names>D.E.</given-names></name>, <etal></etal></person-group>
<year>2011</year>
<article-title>Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes</article-title>. <source/>Nat. Genet.
<volume>44</volume>:<fpage>53</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/ng.1031</pub-id><pub-id pub-id-type="pmid">22158538</pub-id></mixed-citation>
</ref>
<ref id="bib50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gretarsdottir</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Helgason</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Helgadottir</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sigurdsson</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Thorleifsson</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Magnusdottir</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Oddsson</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Steinthorsdottir</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Rafnar</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>de Graaf</surname><given-names>J.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>A splice region variant in <italic>LDLR</italic> lowers non-high density lipoprotein cholesterol and protects against coronary artery disease</article-title>. <source/>PLoS Genet.
<volume>11</volume>:<fpage>e1005379</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005379</pub-id><pub-id pub-id-type="pmid">26327206</pub-id></mixed-citation>
</ref>
<ref id="bib51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Schafer</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Greaser</surname><given-names>M.L.</given-names></name>, <name name-style="western"><surname>Radke</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Liss</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Govindarajan</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Maatz</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Schulz</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Parrish</surname><given-names>A.M.</given-names></name>, <etal></etal></person-group>
<year>2012</year>
<article-title>RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing</article-title>. <source/>Nat. Med.
<volume>18</volume>:<fpage>766</fpage>–<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2693</pub-id><pub-id pub-id-type="pmid">22466703</pub-id></mixed-citation>
</ref>
<ref id="bib52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gutschner</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hammerle</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Diederichs</surname><given-names>S.</given-names></name></person-group>
<year>2013</year>
<article-title><italic>MALAT1</italic> — a paradigm for long noncoding RNA function in cancer</article-title>. <source/>J. Mol. Med.
<volume>91</volume>:<fpage>791</fpage>–<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-013-1028-y</pub-id><pub-id pub-id-type="pmid">23529762</pub-id></mixed-citation>
</ref>
<ref id="bib53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hales</surname><given-names>C.M.</given-names></name>, <name name-style="western"><surname>Seyfried</surname><given-names>N.T.</given-names></name>, <name name-style="western"><surname>Dammer</surname><given-names>E.B.</given-names></name>, <name name-style="western"><surname>Duong</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Gearing</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Troncoso</surname><given-names>J.C.</given-names></name>, <name name-style="western"><surname>Mufson</surname><given-names>E.J.</given-names></name>, <name name-style="western"><surname>Thambisetty</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Levey</surname><given-names>A.I.</given-names></name>, and <name name-style="western"><surname>Lah</surname><given-names>J.J.</given-names></name></person-group>
<year>2014</year>
<article-title>U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer’s disease due to autosomal dominant genetic mutations and trisomy 21</article-title>. <source/>Mol. Neurodegener.
<volume>9</volume>:<fpage>15</fpage>
<pub-id pub-id-type="doi">10.1186/1750-1326-9-15</pub-id><pub-id pub-id-type="pmid">24773620</pub-id></mixed-citation>
</ref>
<ref id="bib54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herman</surname><given-names>D.S.</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>M.R.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Teekakirikul</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Christodoulou</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Conner</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>DePalma</surname><given-names>S.R.</given-names></name>, <name name-style="western"><surname>McDonough</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Sparks</surname><given-names>E.</given-names></name>, <etal></etal></person-group>
<year>2012</year>
<article-title>Truncations of titin causing dilated cardiomyopathy</article-title>. <source/>N. Engl. J. Med.
<volume>366</volume>:<fpage>619</fpage>–<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1110186</pub-id><pub-id pub-id-type="pmid">22335739</pub-id></mixed-citation>
</ref>
<ref id="bib55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Highley</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Kirby</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Jansweijer</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Webb</surname><given-names>P.S.</given-names></name>, <name name-style="western"><surname>Hewamadduma</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Heath</surname><given-names>P.R.</given-names></name>, <name name-style="western"><surname>Higginbottom</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Raman</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ferraiuolo</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Cooper-Knock</surname><given-names>J.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones</article-title>. <source/>Neuropathol. Appl. Neurobiol.
<volume>40</volume>:<fpage>670</fpage>–<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1111/nan.12148</pub-id><pub-id pub-id-type="pmid">24750229</pub-id></mixed-citation>
</ref>
<ref id="bib56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsu</surname><given-names>T.Y.</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>L.M.</given-names></name>, <name name-style="western"><surname>Neill</surname><given-names>N.J.</given-names></name>, <name name-style="western"><surname>Marcotte</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sayad</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bland</surname><given-names>C.S.</given-names></name>, <name name-style="western"><surname>Echeverria</surname><given-names>G.V.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kurley</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Tyagi</surname><given-names>S.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>The spliceosome is a therapeutic vulnerability in MYC-driven cancer</article-title>. <source/>Nature.
<volume>525</volume>:<fpage>384</fpage>–<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1038/nature14985</pub-id><pub-id pub-id-type="pmid">26331541</pub-id></mixed-citation>
</ref>
<ref id="bib57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hua</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.H.</given-names></name>, <name name-style="western"><surname>Sahashi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Rigo</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>C.F.</given-names></name>, and <name name-style="western"><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group>
<year>2015</year>
<article-title>Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models</article-title>. <source/>Genes Dev.
<volume>29</volume>:<fpage>288</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1101/gad.256644.114</pub-id><pub-id pub-id-type="pmid">25583329</pub-id></mixed-citation>
</ref>
<ref id="bib58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ilagan</surname><given-names>J.O.</given-names></name>, <name name-style="western"><surname>Ramakrishnan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hayes</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Zebari</surname><given-names>A.S.</given-names></name>, <name name-style="western"><surname>Bradley</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Bradley</surname><given-names>R.K.</given-names></name></person-group>
<year>2015</year>
<article-title>U2AF1 mutations alter splice site recognition in hematological malignancies</article-title>. <source/>Genome Res.
<volume>25</volume>:<fpage>14</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1101/gr.181016.114</pub-id><pub-id pub-id-type="pmid">25267526</pub-id></mixed-citation>
</ref>
<ref id="bib59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Irimia</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Weatheritt</surname><given-names>R.J.</given-names></name>, <name name-style="western"><surname>Ellis</surname><given-names>J.D.</given-names></name>, <name name-style="western"><surname>Parikshak</surname><given-names>N.N.</given-names></name>, <name name-style="western"><surname>Gonatopoulos-Pournatzis</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Babor</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Quesnel-Vallieres</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tapial</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Raj</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>O’Hanlon</surname><given-names>D.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>A highly conserved program of neuronal microexons is misregulated in autistic brains</article-title>. <source/>Cell.
<volume>159</volume>:<fpage>1511</fpage>–<lpage>1523</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.11.035</pub-id><pub-id pub-id-type="pmid">25525873</pub-id></mixed-citation>
</ref>
<ref id="bib60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ittner</surname><given-names>L.M.</given-names></name>, and <name name-style="western"><surname>Gotz</surname><given-names>J.</given-names></name></person-group>
<year>2011</year>
<article-title>Amyloid-β and tau — a toxic <italic>pas de deux</italic> in Alzheimer’s disease</article-title>. <source/>Nat. Rev. Neurosci.
<volume>12</volume>:<fpage>65</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2967</pub-id></mixed-citation>
</ref>
<ref id="bib61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janssens</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Van Broeckhoven</surname><given-names>C.</given-names></name></person-group>
<year>2013</year>
<article-title>Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders</article-title>. <source/>Hum. Mol. Genet.
<volume>22</volume>(<issue>R1</issue>):<fpage>R77</fpage>–<lpage>R87</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt349</pub-id><pub-id pub-id-type="pmid">23900071</pub-id></mixed-citation>
</ref>
<ref id="bib62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kandoth</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>McLellan</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Vandin</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>McMichael</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Wyczalkowski</surname><given-names>M.A.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>Mutational landscape and significance across 12 major cancer types</article-title>. <source/>Nature.
<volume>502</volume>:<fpage>333</fpage>–<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1038/nature12634</pub-id><pub-id pub-id-type="pmid">24132290</pub-id></mixed-citation>
</ref>
<ref id="bib63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karni</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>de Stanchina</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Lowe</surname><given-names>S.W.</given-names></name>, <name name-style="western"><surname>Sinha</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Mu</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group>
<year>2007</year>
<article-title>The gene encoding the splicing factor SF2/ASF is a proto-oncogene</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>14</volume>:<fpage>185</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb1209</pub-id><pub-id pub-id-type="pmid">17310252</pub-id></mixed-citation>
</ref>
<ref id="bib64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelemen</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Convertini</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Falaleeva</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Stamm</surname><given-names>S.</given-names></name></person-group>
<year>2013</year>
<article-title>Function of alternative splicing</article-title>. <source/>Gene.
<volume>514</volume>:<fpage>1</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2012.07.083</pub-id><pub-id pub-id-type="pmid">22909801</pub-id></mixed-citation>
</ref>
<ref id="bib65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kfir</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Lev-Maor</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Glaich</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Alajem</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Datta</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sze</surname><given-names>S.K.</given-names></name>, <name name-style="western"><surname>Meshorer</surname><given-names>E.</given-names></name>, and <name name-style="western"><surname>Ast</surname><given-names>G.</given-names></name></person-group>
<year>2015</year>
<article-title>SF3B1 association with chromatin determines splicing outcomes</article-title>. <source/>Cell Reports.
<volume>11</volume>:<fpage>618</fpage>–<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.03.048</pub-id><pub-id pub-id-type="pmid">25892229</pub-id></mixed-citation>
</ref>
<ref id="bib66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ilagan</surname><given-names>J.O.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Daubner</surname><given-names>G.M.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Ramakrishnan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>Y.R.</given-names></name>, <name name-style="western"><surname>Micol</surname><given-names>J.B.</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>M.E.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title><italic>SRSF2</italic> mutations contribute to myelodysplasia by mutant-specific effects on exon recognition</article-title>. <source/>Cancer Cell.
<volume>27</volume>:<fpage>617</fpage>–<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccell.2015.04.006</pub-id><pub-id pub-id-type="pmid">25965569</pub-id></mixed-citation>
</ref>
<ref id="bib67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.J.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>N.C.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.D.</given-names></name>, <name name-style="western"><surname>Scarborough</surname><given-names>E.A.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Diaz</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>MacLea</surname><given-names>K.S.</given-names></name>, <name name-style="western"><surname>Freibaum</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Molliex</surname><given-names>A.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS</article-title>. <source/>Nature.
<volume>495</volume>:<fpage>467</fpage>–<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1038/nature11922</pub-id><pub-id pub-id-type="pmid">23455423</pub-id></mixed-citation>
</ref>
<ref id="bib68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koh</surname><given-names>C.M.</given-names></name>, <name name-style="western"><surname>Bezzi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Low</surname><given-names>D.H.</given-names></name>, <name name-style="western"><surname>Ang</surname><given-names>W.X.</given-names></name>, <name name-style="western"><surname>Teo</surname><given-names>S.X.</given-names></name>, <name name-style="western"><surname>Gay</surname><given-names>F.P.</given-names></name>, <name name-style="western"><surname>Al-Haddawi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>S.Y.</given-names></name>, <name name-style="western"><surname>Osato</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sabo</surname><given-names>A.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis</article-title>. <source/>Nature.
<volume>523</volume>:<fpage>96</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1038/nature14351</pub-id><pub-id pub-id-type="pmid">25970242</pub-id></mixed-citation>
</ref>
<ref id="bib69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Komeno</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Y.J.</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Monterroza</surname><given-names>D.D.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>DeKelver</surname><given-names>R.C.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>SRSF2 is essential for hematopoiesis, and its myelodysplastic syndrome-related mutations dysregulate alternative pre-mRNA splicing</article-title>. <source/>Mol. Cell. Biol.
<volume>35</volume>:<fpage>3071</fpage>–<lpage>3082</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00202-15</pub-id><pub-id pub-id-type="pmid">26124281</pub-id></mixed-citation>
</ref>
<ref id="bib70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurtovic-Kozaric</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Przychodzen</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Konarska</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Clemente</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Otrock</surname><given-names>Z.K.</given-names></name>, <name name-style="western"><surname>Nakashima</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hsi</surname><given-names>E.D.</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Shiraishi</surname><given-names>Y.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>PRPF8 defects cause missplicing in myeloid malignancies</article-title>. <source/>Leukemia.
<volume>29</volume>:<fpage>126</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1038/leu.2014.144</pub-id><pub-id pub-id-type="pmid">24781015</pub-id></mixed-citation>
</ref>
<ref id="bib71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lagier-Tourenne</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Polymenidou</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hutt</surname><given-names>K.R.</given-names></name>, <name name-style="western"><surname>Vu</surname><given-names>A.Q.</given-names></name>, <name name-style="western"><surname>Baughn</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Huelga</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Clutario</surname><given-names>K.M.</given-names></name>, <name name-style="western"><surname>Ling</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>T.Y.</given-names></name>, <name name-style="western"><surname>Mazur</surname><given-names>C.</given-names></name>, <etal></etal></person-group>
<year>2012</year>
<article-title>Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs</article-title>. <source/>Nat. Neurosci.
<volume>15</volume>:<fpage>1488</fpage>–<lpage>1497</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3230</pub-id><pub-id pub-id-type="pmid">23023293</pub-id></mixed-citation>
</ref>
<ref id="bib72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>Y.</given-names></name>, and <name name-style="western"><surname>Rio</surname><given-names>D.C.</given-names></name></person-group>
<year>2015</year>
<article-title>Mechanisms and regulation of alternative pre-mRNA splicing</article-title>. <source/>Annu. Rev. Biochem.
<volume>84</volume>:<fpage>291</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-060614-034316</pub-id><pub-id pub-id-type="pmid">25784052</pub-id></mixed-citation>
</ref>
<ref id="bib73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>Y.B.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H.J.</given-names></name>, <name name-style="western"><surname>Peres</surname><given-names>J.N.</given-names></name>, <name name-style="western"><surname>Gomez-Deza</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Attig</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Stalekar</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Troakes</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Nishimura</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Scotter</surname><given-names>E.L.</given-names></name>, <name name-style="western"><surname>Vance</surname><given-names>C.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic</article-title>. <source/>Cell Reports.
<volume>5</volume>:<fpage>1178</fpage>–<lpage>1186</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.10.049</pub-id><pub-id pub-id-type="pmid">24290757</pub-id></mixed-citation>
</ref>
<ref id="bib74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LeFave</surname><given-names>C.V.</given-names></name>, <name name-style="western"><surname>Squatrito</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Vorlova</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rocco</surname><given-names>G.L.</given-names></name>, <name name-style="western"><surname>Brennan</surname><given-names>C.W.</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>E.C.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>Y.X.</given-names></name>, and <name name-style="western"><surname>Cartegni</surname><given-names>L.</given-names></name></person-group>
<year>2011</year>
<article-title>Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas</article-title>. <source/>EMBO J.
<volume>30</volume>:<fpage>4084</fpage>–<lpage>4097</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2011.259</pub-id><pub-id pub-id-type="pmid">21915099</pub-id></mixed-citation>
</ref>
<ref id="bib75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, and <name name-style="western"><surname>Manley</surname><given-names>J.L.</given-names></name></person-group>
<year>2005</year>
<article-title>Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability</article-title>. <source/>Cell.
<volume>122</volume>:<fpage>365</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2005.06.008</pub-id><pub-id pub-id-type="pmid">16096057</pub-id></mixed-citation>
</ref>
<ref id="bib76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>C.H.</given-names></name>, <name name-style="western"><surname>Stoilov</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>X.D.</given-names></name>, and <name name-style="western"><surname>Black</surname><given-names>D.L.</given-names></name></person-group>
<year>2014</year>
<article-title>The splicing regulator PTBP2 controls a program of embryonic splicing required for neuronal maturation</article-title>. <source/>eLife.
<volume>3</volume>:<fpage>e01201</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.01201</pub-id><pub-id pub-id-type="pmid">24448406</pub-id></mixed-citation>
</ref>
<ref id="bib77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Manley</surname><given-names>J.L.</given-names></name></person-group>
<year>2007</year>
<article-title>The RNA binding protein RNPS1 alleviates ASF/SF2 depletion-induced genomic instability</article-title>. <source/>RNA.
<volume>13</volume>:<fpage>2108</fpage>–<lpage>2115</lpage>. <pub-id pub-id-type="doi">10.1261/rna.734407</pub-id><pub-id pub-id-type="pmid">17959926</pub-id></mixed-citation>
</ref>
<ref id="bib78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.I.</given-names></name>, <name name-style="western"><surname>Sanchez-Pulido</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Haerty</surname><given-names>W.</given-names></name>, and <name name-style="western"><surname>Ponting</surname><given-names>C.P.</given-names></name></person-group>
<year>2015</year>
<article-title>RBFOX and PTBP1 proteins regulate the alternative splicing of micro-exons in human brain transcripts</article-title>. <source/>Genome Res.
<volume>25</volume>:<fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1101/gr.181990.114</pub-id></mixed-citation>
</ref>
<ref id="bib79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Licatalosi</surname><given-names>D.D.</given-names></name>, <name name-style="western"><surname>Yano</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fak</surname><given-names>J.J.</given-names></name>, <name name-style="western"><surname>Mele</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Grabinski</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Darnell</surname><given-names>R.B.</given-names></name></person-group>
<year>2012</year>
<article-title>Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain</article-title>. <source/>Genes Dev.
<volume>26</volume>:<fpage>1626</fpage>–<lpage>1642</lpage>. <pub-id pub-id-type="doi">10.1101/gad.191338.112</pub-id><pub-id pub-id-type="pmid">22802532</pub-id></mixed-citation>
</ref>
<ref id="bib80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ling</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Pletnikova</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Troncoso</surname><given-names>J.C.</given-names></name>, and <name name-style="western"><surname>Wong</surname><given-names>P.C.</given-names></name></person-group>
<year>2015</year>
<article-title>TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD</article-title>. <source/>Science.
<volume>349</volume>:<fpage>650</fpage>–<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1126/science.aab0983</pub-id><pub-id pub-id-type="pmid">26250685</pub-id></mixed-citation>
</ref>
<ref id="bib81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>J.C.</given-names></name>, and <name name-style="western"><surname>Caceres</surname><given-names>J.F.</given-names></name></person-group>
<year>2009</year>
<article-title>The SR protein family of splicing factors: Master regulators of gene expression</article-title>. <source/>Biochem. J.
<volume>417</volume>:<fpage>15</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20081501</pub-id><pub-id pub-id-type="pmid">19061484</pub-id></mixed-citation>
</ref>
<ref id="bib82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Love</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Hayden</surname><given-names>E.J.</given-names></name>, and <name name-style="western"><surname>Rohn</surname><given-names>T.T.</given-names></name></person-group>
<year>2015</year>
<article-title>Alternative splicing in Alzheimer’s disease</article-title>. <source/>J. Parkinsons Dis. Alzheimers Dis.
<volume>2</volume>:<fpage>6</fpage>.<pub-id pub-id-type="pmid">26942228</pub-id></mixed-citation>
</ref>
<ref id="bib83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luco</surname><given-names>R.F.</given-names></name>, <name name-style="western"><surname>Allo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Schor</surname><given-names>I.E.</given-names></name>, <name name-style="western"><surname>Kornblihtt</surname><given-names>A.R.</given-names></name>, and <name name-style="western"><surname>Misteli</surname><given-names>T.</given-names></name></person-group>
<year>2011</year>
<article-title>Epigenetics in alternative pre-mRNA splicing</article-title>. <source/>Cell.
<volume>144</volume>:<fpage>16</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.11.056</pub-id><pub-id pub-id-type="pmid">21215366</pub-id></mixed-citation>
</ref>
<ref id="bib84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Solimini</surname><given-names>N.L.</given-names></name>, and <name name-style="western"><surname>Elledge</surname><given-names>S.J.</given-names></name></person-group>
<year>2009</year>
<article-title>Principles of cancer therapy: Oncogene and non-oncogene addiction</article-title>. <source/>Cell.
<volume>136</volume>:<fpage>823</fpage>–<lpage>837</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.02.024</pub-id><pub-id pub-id-type="pmid">19269363</pub-id></mixed-citation>
</ref>
<ref id="bib85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madan</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Kanojia</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Okamoto</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sato-Otsubo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kohlmann</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sanada</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Grossmann</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Sundaresan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shiraishi</surname><given-names>Y.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome</article-title>. <source/>Nat. Commun.
<volume>6</volume>:<fpage>6042</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms7042</pub-id><pub-id pub-id-type="pmid">25586593</pub-id></mixed-citation>
</ref>
<ref id="bib86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maguire</surname><given-names>S.L.</given-names></name>, <name name-style="western"><surname>Leonidou</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wai</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Marchio</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>C.K.</given-names></name>, <name name-style="western"><surname>Sapino</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Salomon</surname><given-names>A.V.</given-names></name>, <name name-style="western"><surname>Reis-Filho</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Weigelt</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Natrajan</surname><given-names>R.C.</given-names></name></person-group>
<year>2015</year>
<article-title>SF3B1 mutations constitute a novel therapeutic target in breast cancer</article-title>. <source/>J. Pathol.
<volume>235</volume>:<fpage>571</fpage>–<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1002/path.4483</pub-id><pub-id pub-id-type="pmid">25424858</pub-id></mixed-citation>
</ref>
<ref id="bib87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makishima</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Visconte</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Jankowska</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Abu Kar</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Jerez</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Przychodzen</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Bupathi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Guinta</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Afable</surname><given-names>M.G.</given-names></name>, <etal></etal></person-group>
<year>2012</year>
<article-title>Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis</article-title>. <source/>Blood.
<volume>119</volume>:<fpage>3203</fpage>–<lpage>3210</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2011-12-399774</pub-id><pub-id pub-id-type="pmid">22323480</pub-id></mixed-citation>
</ref>
<ref id="bib88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Massiello</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Roesser</surname><given-names>J.R.</given-names></name>, and <name name-style="western"><surname>Chalfant</surname><given-names>C.E.</given-names></name></person-group>
<year>2006</year>
<article-title>SAP155 binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5′ splice site selection of Bcl-x pre-mRNA</article-title>. <source/>FASEB J.
<volume>20</volume>:<fpage>1680</fpage>–<lpage>1682</lpage>. <pub-id pub-id-type="doi">10.1096/fj.05-5021fje</pub-id><pub-id pub-id-type="pmid">16790528</pub-id></mixed-citation>
</ref>
<ref id="bib89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matera</surname><given-names>A.G.</given-names></name>, and <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name></person-group>
<year>2014</year>
<article-title>A day in the life of the spliceosome</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>15</volume>:<fpage>108</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3742</pub-id><pub-id pub-id-type="pmid">24452469</pub-id></mixed-citation>
</ref>
<ref id="bib90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsunawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sanada</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sato-Otsubo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Shiozawa</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Otsu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Shiraishi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Miyano</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Isono</surname><given-names>K.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia</article-title>. <source/>Leukemia.
<volume>28</volume>:<fpage>1844</fpage>–<lpage>1850</lpage>. <pub-id pub-id-type="doi">10.1038/leu.2014.73</pub-id><pub-id pub-id-type="pmid">24535406</pub-id></mixed-citation>
</ref>
<ref id="bib91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matter</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Herrlich</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Konig</surname><given-names>H.</given-names></name></person-group>
<year>2002</year>
<article-title>Signal-dependent regulation of splicing via phosphorylation of Sam68</article-title>. <source/>Nature.
<volume>420</volume>:<fpage>691</fpage>–<lpage>695</lpage>. <pub-id pub-id-type="doi">10.1038/nature01153</pub-id><pub-id pub-id-type="pmid">12478298</pub-id></mixed-citation>
</ref>
<ref id="bib92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mirtschink</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Krishnan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Grimm</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Sarre</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Horl</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kayikci</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fankhauser</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Christinat</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Cortijo</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Feehan</surname><given-names>O.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease</article-title>. <source/>Nature.
<volume>522</volume>:<fpage>444</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1038/nature14508</pub-id><pub-id pub-id-type="pmid">26083752</pub-id></mixed-citation>
</ref>
<ref id="bib93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mykowska</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sobczak</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Wojciechowska</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kozlowski</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Krzyzosiak</surname><given-names>W.J.</given-names></name></person-group>
<year>2011</year>
<article-title>CAG repeats mimic CUG repeats in the misregulation of alternative splicing</article-title>. <source/>Nucleic Acids Res.
<volume>39</volume>:<fpage>8938</fpage>–<lpage>8951</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr608</pub-id><pub-id pub-id-type="pmid">21795378</pub-id></mixed-citation>
</ref>
<ref id="bib94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naftelberg</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schor</surname><given-names>I.E.</given-names></name>, <name name-style="western"><surname>Ast</surname><given-names>G.</given-names></name>, and <name name-style="western"><surname>Kornblihtt</surname><given-names>A.R.</given-names></name></person-group>
<year>2015</year>
<article-title>Regulation of alternative splicing through coupling with transcription and chromatin structure</article-title>. <source/>Annu. Rev. Biochem.
<volume>84</volume>:<fpage>165</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-060614-034242</pub-id><pub-id pub-id-type="pmid">26034889</pub-id></mixed-citation>
</ref>
<ref id="bib95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naro</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Sette</surname><given-names>C.</given-names></name></person-group>
<year>2013</year>
<article-title>Phosphorylation-mediated regulation of alternative splicing in cancer</article-title>. <source/>Int. J. Cell Biol.
<volume>2013</volume>:<fpage>151839</fpage>
<pub-id pub-id-type="doi">10.1155/2013/151839</pub-id><pub-id pub-id-type="pmid">24069033</pub-id></mixed-citation>
</ref>
<ref id="bib96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naryshkin</surname><given-names>N.A.</given-names></name>, <name name-style="western"><surname>Weetall</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dakka</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Narasimhan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Ling</surname><given-names>K.K.</given-names></name>, <name name-style="western"><surname>Karp</surname><given-names>G.M.</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Woll</surname><given-names>M.G.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title><italic>SMN2</italic> splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy</article-title>. <source/>Science.
<volume>345</volume>:<fpage>688</fpage>–<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1126/science.1250127</pub-id><pub-id pub-id-type="pmid">25104390</pub-id></mixed-citation>
</ref>
<ref id="bib97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nussbacher</surname><given-names>J.K.</given-names></name>, <name name-style="western"><surname>Batra</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Lagier-Tourenne</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Yeo</surname><given-names>G.W.</given-names></name></person-group>
<year>2015</year>
<article-title>RNA-binding proteins in neurodegeneration: Seq and you shall receive</article-title>. <source/>Trends Neurosci.
<volume>38</volume>:<fpage>226</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2015.02.003</pub-id><pub-id pub-id-type="pmid">25765321</pub-id></mixed-citation>
</ref>
<ref id="bib98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O’Donovan</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Hasselfeld</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Bauer</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Simmons</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Roussos</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Haroutunian</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Meador-Woodruff</surname><given-names>J.H.</given-names></name>, and <name name-style="western"><surname>McCullumsmith</surname><given-names>R.E.</given-names></name></person-group>
<year>2015</year>
<article-title>Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia</article-title>. <source/>Transl. Psychiatry.
<volume>5</volume>:<fpage>e579</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.74</pub-id><pub-id pub-id-type="pmid">26057049</pub-id></mixed-citation>
</ref>
<ref id="bib99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oldmeadow</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Mossman</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Holliday</surname><given-names>E.G.</given-names></name>, <name name-style="western"><surname>Tooney</surname><given-names>P.A.</given-names></name>, <name name-style="western"><surname>Cairns</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Carr</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Attia</surname><given-names>J.R.</given-names></name>, and <name name-style="western"><surname>Scott</surname><given-names>R.J.</given-names></name></person-group>
<year>2014</year>
<article-title>Combined analysis of exon splicing and genome wide polymorphism data predict schizophrenia risk loci</article-title>. <source/>J. Psychiatr. Res.
<volume>52</volume>:<fpage>44</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2014.01.011</pub-id><pub-id pub-id-type="pmid">24507884</pub-id></mixed-citation>
</ref>
<ref id="bib100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olshavsky</surname><given-names>N.A.</given-names></name>, <name name-style="western"><surname>Comstock</surname><given-names>C.E.</given-names></name>, <name name-style="western"><surname>Schiewer</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Augello</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Hyslop</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sette</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Parysek</surname><given-names>L.M.</given-names></name>, and <name name-style="western"><surname>Knudsen</surname><given-names>K.E.</given-names></name></person-group>
<year>2010</year>
<article-title>Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene</article-title>. <source/>Cancer Res.
<volume>70</volume>:<fpage>3975</fpage>–<lpage>3984</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-3468</pub-id><pub-id pub-id-type="pmid">20460515</pub-id></mixed-citation>
</ref>
<ref id="bib101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pacheco</surname><given-names>T.R.</given-names></name>, <name name-style="western"><surname>Moita</surname><given-names>L.F.</given-names></name>, <name name-style="western"><surname>Gomes</surname><given-names>A.Q.</given-names></name>, <name name-style="western"><surname>Hacohen</surname><given-names>N.</given-names></name>, and <name name-style="western"><surname>Carmo-Fonseca</surname><given-names>M.</given-names></name></person-group>
<year>2006</year>
<article-title>RNA interference knockdown of hU2AF35 impairs cell cycle progression and modulates alternative splicing of Cdc25 transcripts</article-title>. <source/>Mol. Biol. Cell.
<volume>17</volume>:<fpage>4187</fpage>–<lpage>4199</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E06-01-0036</pub-id><pub-id pub-id-type="pmid">16855028</pub-id></mixed-citation>
</ref>
<ref id="bib102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pagliarini</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Naro</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Sette</surname><given-names>C.</given-names></name></person-group>
<year>2015</year>
<article-title>Splicing regulation: A molecular device to enhance cancer cell adaptation</article-title>. <source/>BioMed Res. Int.
<volume>2015</volume>:<fpage>543067</fpage>
<pub-id pub-id-type="doi">10.1155/2015/543067</pub-id><pub-id pub-id-type="pmid">26273627</pub-id></mixed-citation>
</ref>
<ref id="bib103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palacino</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Swalley</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Cheung</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Shu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Van Hoosear</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chin</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>C.G.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice</article-title>. <source/>Nat. Chem. Biol.
<volume>11</volume>:<fpage>511</fpage>–<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1837</pub-id><pub-id pub-id-type="pmid">26030728</pub-id></mixed-citation>
</ref>
<ref id="bib104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papaemmanuil</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Cazzola</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Boultwood</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Malcovati</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Vyas</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Bowen</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Pellagatti</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wainscoat</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Hellstrom-Lindberg</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Gambacorti-Passerini</surname><given-names>C.</given-names></name>, <etal></etal></person-group>
<year>2011</year>
<article-title>Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts</article-title>. <source/>N. Engl. J. Med.
<volume>365</volume>:<fpage>1384</fpage>–<lpage>1395</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1103283</pub-id><pub-id pub-id-type="pmid">21995386</pub-id></mixed-citation>
</ref>
<ref id="bib105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papasaikas</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Tejedor</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Vigevani</surname><given-names>L.</given-names></name>, and <name name-style="western"><surname>Valcarcel</surname><given-names>J.</given-names></name></person-group>
<year>2015</year>
<article-title>Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery</article-title>. <source/>Mol. Cell.
<volume>57</volume>:<fpage>7</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2014.10.030</pub-id><pub-id pub-id-type="pmid">25482510</pub-id></mixed-citation>
</ref>
<ref id="bib106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Polymenidou</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lagier-Tourenne</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hutt</surname><given-names>K.R.</given-names></name>, <name name-style="western"><surname>Huelga</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>T.Y.</given-names></name>, <name name-style="western"><surname>Ling</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Wancewicz</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Mazur</surname><given-names>C.</given-names></name>, <etal></etal></person-group>
<year>2011</year>
<article-title>Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43</article-title>. <source/>Nat. Neurosci.
<volume>14</volume>:<fpage>459</fpage>–<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2779</pub-id><pub-id pub-id-type="pmid">21358643</pub-id></mixed-citation>
</ref>
<ref id="bib107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poulikakos</surname><given-names>P.I.</given-names></name>, <name name-style="western"><surname>Persaud</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Janakiraman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kong</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Moriceau</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Atefi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Titz</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Gabay</surname><given-names>M.T.</given-names></name>, <etal></etal></person-group>
<year>2011</year>
<article-title>RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)</article-title>. <source/>Nature.
<volume>480</volume>:<fpage>387</fpage>–<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1038/nature10662</pub-id><pub-id pub-id-type="pmid">22113612</pub-id></mixed-citation>
</ref>
<ref id="bib108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poulos</surname><given-names>M.G.</given-names></name>, <name name-style="western"><surname>Batra</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Charizanis</surname><given-names>K.</given-names></name>, and <name name-style="western"><surname>Swanson</surname><given-names>M.S.</given-names></name></person-group>
<year>2011</year>
<article-title>Developments in RNA splicing and disease</article-title>. <source/>Cold Spring Harb. Perspect. Biol.
<volume>3</volume>:<fpage>a000778</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a000778</pub-id><pub-id pub-id-type="pmid">21084389</pub-id></mixed-citation>
</ref>
<ref id="bib109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prudencio</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Belzil</surname><given-names>V.V.</given-names></name>, <name name-style="western"><surname>Batra</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Gendron</surname><given-names>T.F.</given-names></name>, <name name-style="western"><surname>Pregent</surname><given-names>L.J.</given-names></name>, <name name-style="western"><surname>Murray</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Overstreet</surname><given-names>K.K.</given-names></name>, <name name-style="western"><surname>Piazza-Johnston</surname><given-names>A.E.</given-names></name>, <name name-style="western"><surname>Desaro</surname><given-names>P.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS</article-title>. <source/>Nat. Neurosci.
<volume>18</volume>:<fpage>1175</fpage>–<lpage>1182</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4065</pub-id><pub-id pub-id-type="pmid">26192745</pub-id></mixed-citation>
</ref>
<ref id="bib110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Przychodzen</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Jerez</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Guinta</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Sekeres</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Padgett</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Maciejewski</surname><given-names>J.P.</given-names></name>, and <name name-style="western"><surname>Makishima</surname><given-names>H.</given-names></name></person-group>
<year>2013</year>
<article-title>Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms</article-title>. <source/>Blood.
<volume>122</volume>:<fpage>999</fpage>–<lpage>1006</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2013-01-480970</pub-id><pub-id pub-id-type="pmid">23775717</pub-id></mixed-citation>
</ref>
<ref id="bib111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quesada</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Conde</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Villamor</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ordonez</surname><given-names>G.R.</given-names></name>, <name name-style="western"><surname>Jares</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Bassaganyas</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Ramsay</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Bea</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pinyol</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Martinez-Trillos</surname><given-names>A.</given-names></name>, <etal></etal></person-group>
<year>2011</year>
<article-title>Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia</article-title>. <source/>Nat. Genet.
<volume>44</volume>:<fpage>47</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1038/ng.1032</pub-id><pub-id pub-id-type="pmid">22158541</pub-id></mixed-citation>
</ref>
<ref id="bib112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quesnel-Vallières</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Irimia</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cordes</surname><given-names>S.P.</given-names></name>, and <name name-style="western"><surname>Blencowe</surname><given-names>B.J.</given-names></name></person-group>
<year>2015</year>
<article-title>Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development</article-title>. <source/>Genes Dev.
<volume>29</volume>:<fpage>746</fpage>–<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1101/gad.256115.114</pub-id><pub-id pub-id-type="pmid">25838543</pub-id></mixed-citation>
</ref>
<ref id="bib113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raj</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Blencowe</surname><given-names>B.J.</given-names></name></person-group>
<year>2015</year>
<article-title>Alternative splicing in the mammalian nervous system: Recent insights into mechanisms and functional roles</article-title>. <source/>Neuron.
<volume>87</volume>:<fpage>14</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.05.004</pub-id><pub-id pub-id-type="pmid">26139367</pub-id></mixed-citation>
</ref>
<ref id="bib114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramos</surname><given-names>A.D.</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>R.E.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Nowakowski</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Gertz</surname><given-names>C.C.</given-names></name>, <name name-style="western"><surname>Salinas</surname><given-names>R.D.</given-names></name>, <name name-style="western"><surname>Zarabi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kriegstein</surname><given-names>A.R.</given-names></name>, and <name name-style="western"><surname>Lim</surname><given-names>D.A.</given-names></name></person-group>
<year>2015</year>
<article-title>The long noncoding RNA <italic>Pnky</italic> regulates neuronal differentiation of embryonic and postnatal neural stem cells</article-title>. <source/>Cell Stem Cell.
<volume>16</volume>:<fpage>439</fpage>–<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2015.02.007</pub-id><pub-id pub-id-type="pmid">25800779</pub-id></mixed-citation>
</ref>
<ref id="bib115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>T.C.</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>K.V.</given-names></name>, and <name name-style="western"><surname>Wood</surname><given-names>M.J.</given-names></name></person-group>
<year>2014</year>
<article-title>The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease</article-title>. <source/>Philos. Trans. R. Soc. Lond. B Biol. Sci.
<volume>369</volume>:<fpage>20130507</fpage>.<pub-id pub-id-type="pmid">25135968</pub-id></mixed-citation>
</ref>
<ref id="bib116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salton</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kasprzak</surname><given-names>W.K.</given-names></name>, <name name-style="western"><surname>Voss</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Shapiro</surname><given-names>B.A.</given-names></name>, <name name-style="western"><surname>Poulikakos</surname><given-names>P.I.</given-names></name>, and <name name-style="western"><surname>Misteli</surname><given-names>T.</given-names></name></person-group>
<year>2015</year>
<article-title>Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing</article-title>. <source/>Nat. Commun.
<volume>6</volume>:<fpage>7103</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms8103</pub-id><pub-id pub-id-type="pmid">25971842</pub-id></mixed-citation>
</ref>
<ref id="bib117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saltzman</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>Q.</given-names></name>, and <name name-style="western"><surname>Blencowe</surname><given-names>B.J.</given-names></name></person-group>
<year>2011</year>
<article-title>Regulation of alternative splicing by the core spliceosomal machinery</article-title>. <source/>Genes Dev.
<volume>25</volume>:<fpage>373</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1101/gad.2004811</pub-id><pub-id pub-id-type="pmid">21325135</pub-id></mixed-citation>
</ref>
<ref id="bib118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sathasivam</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Neueder</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gipson</surname><given-names>T.A.</given-names></name>, <name name-style="western"><surname>Landles</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Benjamin</surname><given-names>A.C.</given-names></name>, <name name-style="western"><surname>Bondulich</surname><given-names>M.K.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>D.L.</given-names></name>, <name name-style="western"><surname>Faull</surname><given-names>R.L.</given-names></name>, <name name-style="western"><surname>Roos</surname><given-names>R.A.</given-names></name>, <name name-style="western"><surname>Howland</surname><given-names>D.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>Aberrant splicing of <italic>HTT</italic> generates the pathogenic exon 1 protein in Huntington disease</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>110</volume>:<fpage>2366</fpage>–<lpage>2370</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1221891110</pub-id><pub-id pub-id-type="pmid">23341618</pub-id></mixed-citation>
</ref>
<ref id="bib119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savage</surname><given-names>K.I.</given-names></name>, <name name-style="western"><surname>Gorski</surname><given-names>J.J.</given-names></name>, <name name-style="western"><surname>Barros</surname><given-names>E.M.</given-names></name>, <name name-style="western"><surname>Irwin</surname><given-names>G.W.</given-names></name>, <name name-style="western"><surname>Manti</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Powell</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Pellagatti</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lukashchuk</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>McCance</surname><given-names>D.J.</given-names></name>, <name name-style="western"><surname>McCluggage</surname><given-names>W.G.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability</article-title>. <source/>Mol. Cell.
<volume>54</volume>:<fpage>445</fpage>–<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2014.03.021</pub-id><pub-id pub-id-type="pmid">24746700</pub-id></mixed-citation>
</ref>
<ref id="bib120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>L.M.</given-names></name>, and <name name-style="western"><surname>Rebel</surname><given-names>V.I.</given-names></name></person-group>
<year>2013</year>
<article-title>Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors</article-title>. <source/>J. Natl. Cancer Inst.
<volume>105</volume>:<fpage>1540</fpage>–<lpage>1549</lpage>. <pub-id pub-id-type="doi">10.1093/jnci/djt257</pub-id><pub-id pub-id-type="pmid">24052622</pub-id></mixed-citation>
</ref>
<ref id="bib121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scotter</surname><given-names>E.L.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H.J.</given-names></name>, and <name name-style="western"><surname>Shaw</surname><given-names>C.E.</given-names></name></person-group>
<year>2015</year>
<article-title>TDP-43 proteinopathy and ALS: Insights into disease mechanisms and therapeutic targets</article-title>. <source/>Neurotherapeutics.
<volume>12</volume>:<fpage>352</fpage>–<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-015-0338-x</pub-id><pub-id pub-id-type="pmid">25652699</pub-id></mixed-citation>
</ref>
<ref id="bib122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sebestyén</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Zawisza</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Eyras</surname><given-names>E.</given-names></name></person-group>
<year>2015</year>
<article-title>Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer</article-title>. <source/>Nucleic Acids Res.
<volume>43</volume>:<fpage>1345</fpage>–<lpage>1356</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1392</pub-id><pub-id pub-id-type="pmid">25578962</pub-id></mixed-citation>
</ref>
<ref id="bib123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sehgal</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Mathur</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Braun</surname><given-names>F.K.</given-names></name>, <name name-style="western"><surname>Wise</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Berkova</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Neelapu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kwak</surname><given-names>L.W.</given-names></name>, and <name name-style="western"><surname>Samaniego</surname><given-names>F.</given-names></name></person-group>
<year>2014</year>
<article-title>FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma</article-title>. <source/>Leukemia.
<volume>28</volume>:<fpage>2376</fpage>–<lpage>2387</lpage>. <pub-id pub-id-type="doi">10.1038/leu.2014.126</pub-id><pub-id pub-id-type="pmid">24811343</pub-id></mixed-citation>
</ref>
<ref id="bib124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shao</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>Mechanisms for U2AF to define 3′ splice sites and regulate alternative splicing in the human genome</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>21</volume>:<fpage>997</fpage>–<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2906</pub-id><pub-id pub-id-type="pmid">25326705</pub-id></mixed-citation>
</ref>
<ref id="bib125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shapiro</surname><given-names>I.M.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>A.W.</given-names></name>, <name name-style="western"><surname>Flytzanis</surname><given-names>N.C.</given-names></name>, <name name-style="western"><surname>Balsamo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Condeelis</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Oktay</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Burge</surname><given-names>C.B.</given-names></name>, and <name name-style="western"><surname>Gertler</surname><given-names>F.B.</given-names></name></person-group>
<year>2011</year>
<article-title>An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype</article-title>. <source/>PLoS Genet.
<volume>7</volume>:<fpage>e1002218</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002218</pub-id><pub-id pub-id-type="pmid">21876675</pub-id></mixed-citation>
</ref>
<ref id="bib126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shilo</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Siegfried</surname><given-names>Z.</given-names></name>, and <name name-style="western"><surname>Karni</surname><given-names>R.</given-names></name></person-group>
<year>2015</year>
<article-title>The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression</article-title>. <source/>Mol. Cell. Oncol.
<volume>2</volume>:<fpage>e970955</fpage>
<pub-id pub-id-type="doi">10.4161/23723548.2014.970955</pub-id><pub-id pub-id-type="pmid">27308389</pub-id></mixed-citation>
</ref>
<ref id="bib127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shirai</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Ley</surname><given-names>J.N.</given-names></name>, <name name-style="western"><surname>White</surname><given-names>B.S.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Tibbitts</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ndonwi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wadugu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Duncavage</surname><given-names>E.J.</given-names></name>, <name name-style="western"><surname>Okeyo-Owuor</surname><given-names>T.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>Mutant U2AF1 expression alters hematopoiesis and pre-mRNA splicing in vivo</article-title>. <source/>Cancer Cell.
<volume>27</volume>:<fpage>631</fpage>–<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccell.2015.04.008</pub-id><pub-id pub-id-type="pmid">25965570</pub-id></mixed-citation>
</ref>
<ref id="bib128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shkreta</surname><given-names>L.</given-names></name>, and <name name-style="western"><surname>Chabot</surname><given-names>B.</given-names></name></person-group>
<year>2015</year>
<article-title>The RNA splicing response to DNA damage</article-title>. <source/>Biomolecules.
<volume>5</volume>:<fpage>2935</fpage>–<lpage>2977</lpage>. <pub-id pub-id-type="doi">10.3390/biom5042935</pub-id><pub-id pub-id-type="pmid">26529031</pub-id></mixed-citation>
</ref>
<ref id="bib129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>R.K.</given-names></name>, and <name name-style="western"><surname>Cooper</surname><given-names>T.A.</given-names></name></person-group>
<year>2012</year>
<article-title>Pre-mRNA splicing in disease and therapeutics</article-title>. <source/>Trends Mol. Med.
<volume>18</volume>:<fpage>472</fpage>–<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2012.06.006</pub-id><pub-id pub-id-type="pmid">22819011</pub-id></mixed-citation>
</ref>
<ref id="bib130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staropoli</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Chun</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Allaire</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Cullen</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Thai</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fleet</surname><given-names>C.M.</given-names></name>, <name name-style="western"><surname>Hua</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>C.F.</given-names></name>, <name name-style="western"><surname>Krainer</surname><given-names>A.R.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>Rescue of gene-expression changes in an induced mouse model of spinal muscular atrophy by an antisense oligonucleotide that promotes inclusion of SMN2 exon 7</article-title>. <source/>Genomics.
<volume>105</volume>:<fpage>220</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2015.01.007</pub-id><pub-id pub-id-type="pmid">25645699</pub-id></mixed-citation>
</ref>
<ref id="bib131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sterne-Weiler</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Sanford</surname><given-names>J.R.</given-names></name></person-group>
<year>2014</year>
<article-title>Exon identity crisis: Disease-causing mutations that disrupt the splicing code</article-title>. <source/>Genome Biol.
<volume>15</volume>:<fpage>201</fpage>
<pub-id pub-id-type="doi">10.1186/gb4150</pub-id><pub-id pub-id-type="pmid">24456648</pub-id></mixed-citation>
</ref>
<ref id="bib132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sveen</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kilpinen</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ruusulehto</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lothe</surname><given-names>R.A.</given-names></name>, and <name name-style="western"><surname>Skotheim</surname><given-names>R.I.</given-names></name></person-group>
<year>2015</year>
<article-title>Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes</article-title>. <source/>Oncogene. In press. <pub-id pub-id-type="doi">10.1038/onc.2015.318</pub-id></mixed-citation>
</ref>
<ref id="bib133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanackovic</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Ransijn</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Thibault</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Abou Elela</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Klinck</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Berson</surname><given-names>E.L.</given-names></name>, <name name-style="western"><surname>Chabot</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Rivolta</surname><given-names>C.</given-names></name></person-group>
<year>2011</year>
<article-title><italic>PRPF</italic> mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa</article-title>. <source/>Hum. Mol. Genet.
<volume>20</volume>:<fpage>2116</fpage>–<lpage>2130</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr094</pub-id><pub-id pub-id-type="pmid">21378395</pub-id></mixed-citation>
</ref>
<ref id="bib134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>J.Y.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.C.</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>M.F.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C.C.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>H.W.</given-names></name>, and <name name-style="western"><surname>Chang</surname><given-names>H.W.</given-names></name></person-group>
<year>2013</year>
<article-title>Alternative splicing for diseases, cancers, drugs, and databases</article-title>. <source/>ScientificWorldJournal.
<volume>2013</volume>:<fpage>703568</fpage>
<pub-id pub-id-type="doi">10.1155/2013/703568</pub-id><pub-id pub-id-type="pmid">23766705</pub-id></mixed-citation>
</ref>
<ref id="bib135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tejedor</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Papasaikas</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Valcarcel</surname><given-names>J.</given-names></name></person-group>
<year>2015</year>
<article-title>Genome-wide identification of Fas/CD95 alternative splicing regulators reveals links with iron homeostasis</article-title>. <source/>Mol. Cell.
<volume>57</volume>:<fpage>23</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2014.10.029</pub-id><pub-id pub-id-type="pmid">25482508</pub-id></mixed-citation>
</ref>
<ref id="bib136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tollervey</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Curk</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Rogelj</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Briese</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cereda</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kayikci</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Konig</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hortobagyi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Nishimura</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Zupunski</surname><given-names>V.</given-names></name>, <etal></etal></person-group>
<year>2011</year>
<article-title>Characterizing the RNA targets and position-dependent splicing regulation by TDP-43</article-title>. <source/>Nat. Neurosci.
<volume>14</volume>:<fpage>452</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2778</pub-id><pub-id pub-id-type="pmid">21358640</pub-id></mixed-citation>
</ref>
<ref id="bib137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tresini</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Warmerdam</surname><given-names>D.O.</given-names></name>, <name name-style="western"><surname>Kolovos</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Snijder</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Vrouwe</surname><given-names>M.G.</given-names></name>, <name name-style="western"><surname>Demmers,</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>van Ijcken</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Grosveld</surname><given-names>F.G.</given-names></name>, <name name-style="western"><surname>Medema</surname><given-names>R.H.</given-names></name>, <name name-style="western"><surname> Hoeijmakers</surname><given-names>J.H.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>The core spliceosome as target and effector of non-canonical ATM signalling</article-title>. <source/>Nature.
<volume>523</volume>:<fpage>53</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1038/nature14512</pub-id><pub-id pub-id-type="pmid">26106861</pub-id></mixed-citation>
</ref>
<ref id="bib138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tripathi</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Ellis</surname><given-names>J.D.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>D.Y.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Watt</surname><given-names>A.T.</given-names></name>, <name name-style="western"><surname>Freier</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>C.F.</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bubulya</surname><given-names>P.A.</given-names></name>, <etal></etal></person-group>
<year>2010</year>
<article-title>The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation</article-title>. <source/>Mol. Cell.
<volume>39</volume>:<fpage>925</fpage>–<lpage>938</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2010.08.011</pub-id><pub-id pub-id-type="pmid">20797886</pub-id></mixed-citation>
</ref>
<ref id="bib139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turunen</surname><given-names>J.J.</given-names></name>, <name name-style="western"><surname>Niemela</surname><given-names>E.H.</given-names></name>, <name name-style="western"><surname>Verma</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Frilander</surname><given-names>M.J.</given-names></name></person-group>
<year>2013</year>
<article-title>The significant other: Splicing by the minor spliceosome</article-title>. <source/>Wiley Interdiscip. Rev. RNA.
<volume>4</volume>:<fpage>61</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1002/wrna.1141</pub-id><pub-id pub-id-type="pmid">23074130</pub-id></mixed-citation>
</ref>
<ref id="bib140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ule</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ule</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Spencer</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Cline</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ruggiu</surname><given-names>M.</given-names></name>, <etal></etal></person-group>
<year>2005</year>
<article-title>Nova regulates brain-specific splicing to shape the synapse</article-title>. <source/>Nat. Genet.
<volume>37</volume>:<fpage>844</fpage>–<lpage>852</lpage>. <pub-id pub-id-type="doi">10.1038/ng1610</pub-id><pub-id pub-id-type="pmid">16041372</pub-id></mixed-citation>
</ref>
<ref id="bib141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valacca</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bonomi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Buratti</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Pedrotti</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Baralle</surname><given-names>F.E.</given-names></name>, <name name-style="western"><surname>Sette</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ghigna</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Biamonti</surname><given-names>G.</given-names></name></person-group>
<year>2010</year>
<article-title>Sam68 regulates EMT through alternative splicing–activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene</article-title>. <source/>J. Cell Biol.
<volume>191</volume>:<fpage>87</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201001073</pub-id><pub-id pub-id-type="pmid">20876280</pub-id></mixed-citation>
</ref>
<ref id="bib142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vanharanta</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Marney</surname><given-names>C.B.</given-names></name>, <name name-style="western"><surname>Shu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Valiente</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Mele</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Darnell</surname><given-names>R.B.</given-names></name>, and <name name-style="western"><surname>Massague</surname><given-names>J.</given-names></name></person-group>
<year>2014</year>
<article-title>Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer</article-title>. <source/>eLife.
<volume>3</volume>:<fpage>e02734</fpage>.</mixed-citation>
</ref>
<ref id="bib143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaz-Drago</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Pinheiro</surname><given-names>M.T.</given-names></name>, <name name-style="western"><surname>Martins</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Enguita</surname><given-names>F.J.</given-names></name>, <name name-style="western"><surname>Carmo-Fonseca</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Custodio</surname><given-names>N.</given-names></name></person-group>
<year>2015</year>
<article-title>Transcription-coupled RNA surveillance in human genetic diseases caused by splice site mutations</article-title>. <source/>Hum. Mol. Genet.
<volume>24</volume>:<fpage>2784</fpage>–<lpage>2795</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv039</pub-id><pub-id pub-id-type="pmid">25652404</pub-id></mixed-citation>
</ref>
<ref id="bib144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Venables</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Klinck</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Koh</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Gervais-Bird</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bramard</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Inkel</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Durand</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Couture</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Froehlich</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Lapointe</surname><given-names>E.</given-names></name>, <etal></etal></person-group>
<year>2009</year>
<article-title>Cancer-associated regulation of alternative splicing</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>16</volume>:<fpage>670</fpage>–<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.1608</pub-id><pub-id pub-id-type="pmid">19448617</pub-id></mixed-citation>
</ref>
<ref id="bib145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Venables</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Brosseau</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Gadea</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Klinck</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Prinos</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Beaulieu</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Lapointe</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Durand</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Thibault</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Tremblay</surname><given-names>K.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues</article-title>. <source/>Mol. Cell. Biol.
<volume>33</volume>:<fpage>396</fpage>–<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.01174-12</pub-id><pub-id pub-id-type="pmid">23149937</pub-id></mixed-citation>
</ref>
<ref id="bib146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visconte</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Rogers</surname><given-names>H.J.</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Barnard</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bupathi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Traina</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>McMahon</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Makishima</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Szpurka</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Jankowska</surname><given-names>A.</given-names></name>, <etal></etal></person-group>
<year>2012</year>
<article-title><italic>SF3B1</italic> haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes</article-title>. <source/>Blood.
<volume>120</volume>:<fpage>3173</fpage>–<lpage>3186</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2012-05-430876</pub-id><pub-id pub-id-type="pmid">22826563</pub-id></mixed-citation>
</ref>
<ref id="bib147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voineagu</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Johnston</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Lowe</surname><given-names>J.K.</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Horvath</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Mill</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cantor</surname><given-names>R.M.</given-names></name>, <name name-style="western"><surname>Blencowe</surname><given-names>B.J.</given-names></name>, and <name name-style="western"><surname>Geschwind</surname><given-names>D.H.</given-names></name></person-group>
<year>2011</year>
<article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title>. <source/>Nature.
<volume>474</volume>:<fpage>380</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1038/nature10110</pub-id><pub-id pub-id-type="pmid">21614001</pub-id></mixed-citation>
</ref>
<ref id="bib148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wahl</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Will</surname><given-names>C.L.</given-names></name>, and <name name-style="western"><surname>Luhrmann</surname><given-names>R.</given-names></name></person-group>
<year>2009</year>
<article-title>The spliceosome: Design principles of a dynamic RNP machine</article-title>. <source/>Cell.
<volume>136</volume>:<fpage>701</fpage>–<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.02.009</pub-id><pub-id pub-id-type="pmid">19239890</pub-id></mixed-citation>
</ref>
<ref id="bib149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walter</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Grillot</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>McLellan</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fulton</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kalicki-Veizer</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>O’Laughlin</surname><given-names>M.</given-names></name>, <etal></etal></person-group>
<year>2011</year>
<article-title>Recurrent DNMT3A mutations in patients with myelodysplastic syndromes</article-title>. <source/>Leukemia.
<volume>25</volume>:<fpage>1153</fpage>–<lpage>1158</lpage>. <pub-id pub-id-type="doi">10.1038/leu.2011.44</pub-id><pub-id pub-id-type="pmid">21415852</pub-id></mixed-citation>
</ref>
<ref id="bib150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sashida</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Saraya</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ishiga</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Koide</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Oshima</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Isono</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Koseki</surname><given-names>H.</given-names></name>, and <name name-style="western"><surname>Iwama</surname><given-names>A.</given-names></name></person-group>
<year>2014</year><comment>a</comment>
<article-title>Depletion of <italic>Sf3b1</italic> impairs proliferative capacity of hematopoietic stem cells but is not sufficient to induce myelodysplasia</article-title>. <source/>Blood.
<volume>123</volume>:<fpage>3336</fpage>–<lpage>3343</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2013-12-544544</pub-id><pub-id pub-id-type="pmid">24735968</pub-id></mixed-citation>
</ref>
<ref id="bib151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, and <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name></person-group>
<year>2014</year><comment>b</comment>
<article-title>LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway</article-title>. <source/>Oncol. Rep.
<volume>31</volume>:<fpage>1839</fpage>–<lpage>1845</lpage>.<pub-id pub-id-type="pmid">24573322</pub-id></mixed-citation>
</ref>
<ref id="bib152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>W.</given-names></name>, and <name name-style="western"><surname>Cui</surname><given-names>Q.</given-names></name></person-group>
<year>2012</year>
<article-title>SpliceDisease database: Linking RNA splicing and disease</article-title>. <source/>Nucleic Acids Res.
<volume>40</volume>(<issue>D1</issue>):<fpage>D1055</fpage>–<lpage>D1059</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr1171</pub-id><pub-id pub-id-type="pmid">22139928</pub-id></mixed-citation>
</ref>
<ref id="bib153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weyn-Vanhentenryck</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Mele</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Farny</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Herre</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Silver</surname><given-names>P.A.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M.Q.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism</article-title>. <source/>Cell Reports.
<volume>6</volume>:<fpage>1139</fpage>–<lpage>1152</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.02.005</pub-id><pub-id pub-id-type="pmid">24613350</pub-id></mixed-citation>
</ref>
<ref id="bib154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wickramasinghe</surname><given-names>V.O.</given-names></name>, <name name-style="western"><surname>Gonzalez-Porta</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Perera</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Bartolozzi</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>Sibley</surname><given-names>C.R.</given-names></name>, <name name-style="western"><surname>Hallegger</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ule</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Marioni</surname><given-names>J.C.</given-names></name>, and <name name-style="western"><surname>Venkitaraman</surname><given-names>A.R.</given-names></name></person-group>
<year>2015</year>
<article-title>Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5′ splice site strength</article-title>. <source/>Genome Biol.
<volume>16</volume>:<fpage>201</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-015-0749-3</pub-id><pub-id pub-id-type="pmid">26392272</pub-id></mixed-citation>
</ref>
<ref id="bib155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>H.Y.</given-names></name>, <name name-style="western"><surname>Alipanahi</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>L.J.</given-names></name>, <name name-style="western"><surname>Bretschneider</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Merico</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Yuen</surname><given-names>R.K.</given-names></name>, <name name-style="western"><surname>Hua</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gueroussov</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Najafabadi</surname><given-names>H.S.</given-names></name>, <name name-style="western"><surname>Hughes</surname><given-names>T.R.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>The human splicing code reveals new insights into the genetic determinants of disease</article-title>. <source/>Science.
<volume>347</volume>:<fpage>1254806</fpage>
<pub-id pub-id-type="doi">10.1126/science.1254806</pub-id><pub-id pub-id-type="pmid">25525159</pub-id></mixed-citation>
</ref>
<ref id="bib156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>X.D.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ahn</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Reinke</surname><given-names>L.M.</given-names></name>, <name name-style="western"><surname>Peter</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gius</surname><given-names>D.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing</article-title>. <source/>Genes Dev.
<volume>28</volume>:<fpage>1191</fpage>–<lpage>1203</lpage>. <pub-id pub-id-type="doi">10.1101/gad.241968.114</pub-id><pub-id pub-id-type="pmid">24840202</pub-id></mixed-citation>
</ref>
<ref id="bib157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group>
<year>2008</year>
<article-title>Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis</article-title>. <source/>Dev. Cell.
<volume>14</volume>:<fpage>818</fpage>–<lpage>829</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2008.05.009</pub-id><pub-id pub-id-type="pmid">18539112</pub-id></mixed-citation>
</ref>
<ref id="bib158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Qiao</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Aliaga</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Salameh</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>McKenna-Yasek</surname><given-names>D.M.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>T.</given-names></name>, <etal></etal></person-group>
<year>2014</year><comment>a</comment>
<article-title>Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>111</volume>:<fpage>E1121</fpage>–<lpage>E1129</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1322641111</pub-id><pub-id pub-id-type="pmid">24616503</pub-id></mixed-citation>
</ref>
<ref id="bib159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>B.D.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Grimm</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Schroth</surname><given-names>G.P.</given-names></name>, <name name-style="western"><surname>Bushel</surname><given-names>P.R.</given-names></name>, <name name-style="western"><surname>Kinyamu</surname><given-names>H.K.</given-names></name>, and <name name-style="western"><surname>Archer</surname><given-names>T.K.</given-names></name></person-group>
<year>2015</year>
<article-title>LIN28A modulates splicing and gene expression programs in breast cancer cells</article-title>. <source/>Mol. Cell. Biol.
<volume>35</volume>:<fpage>3225</fpage>–<lpage>3243</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00426-15</pub-id><pub-id pub-id-type="pmid">26149387</pub-id></mixed-citation>
</ref>
<ref id="bib160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hei</surname><given-names>N.</given-names></name>, and <name name-style="western"><surname>Liang</surname><given-names>H.</given-names></name></person-group>
<year>2014</year><comment>b</comment>
<article-title>Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types</article-title>. <source/>Nat. Commun.
<volume>5</volume>:<fpage>3231</fpage>.<pub-id pub-id-type="pmid">24488081</pub-id></mixed-citation>
</ref>
<ref id="bib161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>C.X.</given-names></name>, <name name-style="western"><surname>Iqbal</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Grundke-Iqbal</surname><given-names>I.</given-names></name>, and <name name-style="western"><surname>Liu</surname><given-names>F.</given-names></name></person-group>
<year>2012</year>
<article-title>Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion</article-title>. <source/>J. Biol. Chem.
<volume>287</volume>:<fpage>30497</fpage>–<lpage>30506</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.355412</pub-id><pub-id pub-id-type="pmid">22767602</pub-id></mixed-citation>
</ref>
<ref id="bib162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Sanada</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Shiraishi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Nowak</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Nagata</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sato-Otsubo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kon</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Nagasaki</surname><given-names>M.</given-names></name>, <etal></etal></person-group>
<year>2011</year>
<article-title>Frequent pathway mutations of splicing machinery in myelodysplasia</article-title>. <source/>Nature.
<volume>478</volume>:<fpage>64</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1038/nature10496</pub-id><pub-id pub-id-type="pmid">21909114</pub-id></mixed-citation>
</ref>
<ref id="bib163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Y.</given-names></name>, and <name name-style="western"><surname>Reed</surname><given-names>R.</given-names></name></person-group>
<year>2015</year>
<article-title>FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>112</volume>:<fpage>8608</fpage>–<lpage>8613</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1506282112</pub-id><pub-id pub-id-type="pmid">26124092</pub-id></mixed-citation>
</ref>
<ref id="bib164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chi</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Gangopadhyay</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yamazaki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Winkelbauer-Hurt</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Eliasse</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>C.E.</given-names></name>, and <name name-style="western"><surname>Reed</surname><given-names>R.</given-names></name></person-group>
<year>2015</year>
<article-title>U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish</article-title>. <source/>Nucleic Acids Res.
<volume>43</volume>:<fpage>3208</fpage>–<lpage>3218</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv157</pub-id><pub-id pub-id-type="pmid">25735748</pub-id></mixed-citation>
</ref>
<ref id="bib165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Peng</surname><given-names>G.</given-names></name></person-group>
<year>2015</year>
<article-title>Non-coding RNAs: An emerging player in DNA damage response</article-title>. <source/>Mutat. Res. Rev. Mutat. Res.
<volume>763</volume>:<fpage>202</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1016/j.mrrev.2014.11.003</pub-id><pub-id pub-id-type="pmid">25795121</pub-id></mixed-citation>
</ref>
<ref id="bib166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Manley</surname><given-names>J.L.</given-names></name></person-group>
<year>2013</year>
<article-title>Misregulation of pre-mRNA alternative splicing in cancer</article-title>. <source/>Cancer Discov.
<volume>3</volume>:<fpage>1228</fpage>–<lpage>1237</lpage>. <pub-id pub-id-type="doi">10.1158/2159-8290.CD-13-0253</pub-id><pub-id pub-id-type="pmid">24145039</pub-id></mixed-citation>
</ref>
<ref id="bib167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Frias</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Mele</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ruggiu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Eom</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Marney</surname><given-names>C.B.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Licatalosi</surname><given-names>D.D.</given-names></name>, <name name-style="western"><surname>Fak</surname><given-names>J.J.</given-names></name>, and <name name-style="western"><surname>Darnell</surname><given-names>R.B.</given-names></name></person-group>
<year>2010</year>
<article-title>Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls</article-title>. <source/>Science.
<volume>329</volume>:<fpage>439</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1126/science.1191150</pub-id><pub-id pub-id-type="pmid">20558669</pub-id></mixed-citation>
</ref>
<ref id="bib168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lieu</surname><given-names>Y.K.</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Penson</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Reggio</surname><given-names>K.S.</given-names></name>, <name name-style="western"><surname>Rabadan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Raza</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Mukherjee</surname><given-names>S.</given-names></name>, and <name name-style="western"><surname>Manley</surname><given-names>J.L.</given-names></name></person-group>
<year>2015</year><comment>a</comment>
<article-title>Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities</article-title>. <source/>Proc. Natl. Acad. Sci. USA. <volume>112</volume>:<fpage>E4726</fpage>–<lpage>E4734</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1514105112</pub-id><pub-id pub-id-type="pmid">26261309</pub-id></mixed-citation>
</ref>
<ref id="bib169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Donnelly</surname><given-names>C.J.</given-names></name>, <name name-style="western"><surname>Haeusler</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>Grima</surname><given-names>J.C.</given-names></name>, <name name-style="western"><surname>Machamer</surname><given-names>J.B.</given-names></name>, <name name-style="western"><surname>Steinwald</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Daley</surname><given-names>E.L.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Cunningham</surname><given-names>K.M.</given-names></name>, <name name-style="western"><surname>Vidensky</surname><given-names>S.</given-names></name>, <etal></etal></person-group>
<year>2015</year><comment>b</comment>
<article-title>The C9orf72 repeat expansion disrupts nucleocytoplasmic transport</article-title>. <source/>Nature. <volume>525</volume>:<fpage>56</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1038/nature14973</pub-id><pub-id pub-id-type="pmid">26308891</pub-id></mixed-citation>
</ref>
<ref id="bib170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Lotti</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Dittmar</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Younis</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Wan</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kasim</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Dreyfuss</surname><given-names>G.</given-names></name></person-group>
<year>2008</year>
<article-title>SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing</article-title>. <source/>Cell.
<volume>133</volume>:<fpage>585</fpage>–<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.03.031</pub-id><pub-id pub-id-type="pmid">18485868</pub-id></mixed-citation>
</ref>
<ref id="bib171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Pinto</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Wan</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Berg</surname><given-names>M.G.</given-names></name>, <name name-style="western"><surname>Oliva</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>L.N.</given-names></name>, <name name-style="western"><surname>Dengler</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>Z.</given-names></name>, and <name name-style="western"><surname>Dreyfuss</surname><given-names>G.</given-names></name></person-group>
<year>2013</year>
<article-title>Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>110</volume>:<fpage>19348</fpage>–<lpage>19353</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1319280110</pub-id><pub-id pub-id-type="pmid">24191055</pub-id></mixed-citation>
</ref>
<ref id="bib172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>H.L.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Wise</surname><given-names>J.A.</given-names></name>, and <name name-style="western"><surname>Lou</surname><given-names>H.</given-names></name></person-group>
<year>2014</year><comment>a</comment>
<article-title>Regulation of alternative splicing by local histone modifications: Potential roles for RNA-guided mechanisms</article-title>. <source/>Nucleic Acids Res.
<volume>42</volume>:<fpage>701</fpage>–<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt875</pub-id><pub-id pub-id-type="pmid">24081581</pub-id></mixed-citation>
</ref>
<ref id="bib173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hasty</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Walter</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Bishop</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>L.M.</given-names></name>, and <name name-style="western"><surname>Rebel</surname><given-names>V.I.</given-names></name></person-group>
<year>2013</year>
<article-title>Myelodysplastic syndrome: An inability to appropriately respond to damaged DNA?</article-title>
<source/>Exp. Hematol.
<volume>41</volume>:<fpage>665</fpage>–<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1016/j.exphem.2013.04.008</pub-id><pub-id pub-id-type="pmid">23643835</pub-id></mixed-citation>
</ref>
<ref id="bib174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Xi</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Feng</surname><given-names>Y.</given-names></name></person-group>
<year>2014</year><comment>b</comment>
<article-title>BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells</article-title>. <source/>Nat. Commun.
<volume>5</volume>:<fpage>4581</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms5581</pub-id><pub-id pub-id-type="pmid">25091051</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>